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This thesis consists of two parts – Part I (Chapter 1-5):  structural and functional 
analysis of two methyltransferases from two different species of the genus 
Bacteroides. Part II (Chapter 6-7) consist of the biophysical characterization of two 
neuron specific protein kinase C (PKC) substrate proteins Neuromodulin (Nm) and 
Neurogranin (Ng), and its structure of the IQ domain in complex with Calmodulin 
(CaM).  
Methylation is important for various cellular activities. More often methyltransferases 
are involved in cellular and metabolic functions. To-date there is no report of any 
methyltransferase structure from human intestine antibiotic resistance pathogenic 
strains B. thetaiotaomicron   VPI-5482 and B. vulgatus ATCC-8482.  Chapter 1 
provides general introduction for this part. Chapter 2 report the expression, 
purification and crystallization of methyltransferases BT_2972 and BVU_3255 from 
the species B. thetaiotaomicron   VPI-5482 and B. vulgatus ATCC-8482 respectively. 
These two MTases were cloned, over expressed and purified to yield approximately 
120 mg of each protein from 1 L of the culture.   Apo BT_2972 and BVU_3255 and 
their complexes with AdoMet/AdoHcy were crystallized in four different crystal 
forms using hanging drop vapour diffusion method. These crystals diffract to a 
resolution ranging from 2.9 to 2.2 Å.  
Chapter 3, report the crystal structure of an AdoMet dependent methyltransferase 
BT_2972 and its complex with AdoMet and AdoHcy from B. thetaiotaomicron   VPI-
5482 strain along with their isothermal titration calorimetric studies.  The active site 
of apo BT_2972 and structures of its complex with AdoMet and AdoHcy revealed 
significant conformational changes which resulted in open and closed forms to 
regulate the movement of cofactors and to aid its interaction with the substrate.  
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Based on our analysis, supported with literature, we suggest that BT_2972 is a small 
molecule methyltransferase and might catalyze two O-methylation reaction steps in 
the ubiquinone biosynthesis pathway.   
BVU_3255 belongs to an AdoMet- dependent methyltransferase. Chapter 4 report the 
crystal structure of apo BVU_3255, and its complexes with AdoMet and AdoHcy, 
which revealed a typical class I Rossmann Fold Methyltransferase. The isothermal 
titration calorimetric study showed that both AdoMet and AdoHcy bind with equal 
affinity. The structural and sequence analysis suggested that BVU_3255 is a small 
molecule methyltransferase and might involve in methylating the intermediates in 
ubiquinone biosynthesis pathway. The conclusions and future directions are provided 
in chapter 5. 
In part II, the chapter 6 of this thesis discuss the biophysical characterization and 
structure of two neuron specific protein kinase C (PKC) substrate proteins 
Neuromodulin (Nm) and Neurogranin (Ng) fragments in complex with Calmodulin 
(CaM). The ubiquitous Ca2+ sensing protein CaM is also under go methylation at the 
Met residues as a part of post translational modification. 
Biophysical studies clearly showed the unfolded state of Ng/Nm in the solutions. 
These classes of proteins are known as intrinsically unstructured protein and they are 
highly flexible and lack the globular fold. However they are functionally active 
proteins in vivo and in vitro conditions.   Further we report the crystal structure of 
CaM binding motif (IQ motif) of Nm and Ng, in complex with apo and Ca2+/CaM.  In 
the presence of IQ peptides, Ca2+/CaM adopt an unusual conformation, hither to not 
observed for any CaM structure. Moreover the crystal structure of apo CaM and IQ 
peptides showed that CaM adopts an extended conformation and the IQ peptides bind 
to C lobe of the CaM. In addition we have carried out interaction studies using 
 ix
isothermal calorimetry. The ITC results and structural studies showed that only a 
small motif of full length Nm and Ng is sufficient to make interactions with CaM. 
Further the present studies  clearly explains the reason why Nm and Ng  shows 1) 
novel CaM binding properties; 2) low affinity for Ca2+/CaM and 3) higher affinity for 
apo CaM.  The present crystal structure is the first report of any neuron specific 
intrinsically unstructured proteins and explains how the unstructured proteins gain 
structure upon binding with its partners. Chapter 7 provides the conclusion and future 
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substrate binding region of BT_2972-AdoHcy is shown as yellow dotted 
surface. C) The inferred substrate binding site also is shown in surface 
diagram D) Similarity between CTAB and the proposed substrate for 
BT_2972 E) Conformation change in the fragment Glu121-Ile127 with 
respect to the substrate binding site. 
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Methylation of key biological molecules and proteins plays important roles in 
numerous biological systems, including signal transduction, biosynthesis, protein 
repair, gene silencing and chromatin regulation (Cheng, 1995). 
Methyltransferases (EC 2.1.1) catalyze the transfer of a methyl group from a donor 
molecule to variety of acceptor molecules. Methyltransferases use a reactive methyl 
group bound to sulfur in AdoMet as the methyl donor. In these reactions, methyl 
group is transferred from an AdoMet molecule to acceptor molecule yielding S-
adenosylhomocysteine (AdoHCy or SAH) and a methylated target molecule. 
Methyltransferase are abundant, highly conserved across phylogeny, biologically 
important class of enzymes. Many of these reactions are very important for the proper 
functioning of life. The lack of the gene product that performs these methyl transfer 
reactions is sufficient to stop the normal functioning of organisms. 95% of 
methyltransferase use S-adenosyl-L-methionine (AdoMet or SAM) as the methyl 
donor. AdoMet is the second most commonly used enzymatic cofactor after ATP. 
The preference for AdoMet over other methyl donor (such as floate) is because of 
favourable energetic (Cantoni, 1975). Aberrant levels of SAM have been linked to 
many abnormalities, including Alzheimer’s, depression, Parkinson’s, multiple 
sclerosis, liver failure and cancer (Schubert et al., 2003) . The comparison shows the 
importance of methyltransferase reactions in living organism. Thus it requires 
immediate need to characterize the methyltransferases structurally and functionally.  
AdoMet is produced from methionine and ATP in the reactions catalyzed by S-
adenosylmethionine synthetase (Figure 1.1). AdoMet serves as precursors for 
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numerous methyl transfer reactions. These methyltransferase enzymes are called as 









Figure 1.1: Biosynthesis reaction of AdoMet. A condensation of ATP and 
methionine is catalyzed by methionine adenosyltransferase yields AdoMet. The 

















General methylation mechanism involves catalytic attack of a nucleophile (carbon, 
oxygen, nitrogen, sulfur or even halides) from the acceptor molecules on a methyl 
group of AdoMet. All methylation reaction takes place with direct transfer of methyl 
group to the acceptor molecule with inversion symmetry in an SN2 like mechanism.  
It also requires that a proton be removed before or after methyl transfer (Woodard et 
al., 1980). Final reaction products are methylated derivative of acceptor molecule and 
AdoHcy (SAH). Methylation reactions produce derivatives with less hydrophilicity 
than unmethylated counterpart (Figure 1.2).  
AdoMet dependent methyltransferase methylate a wide variety of molecular targets 
(methyl group acceptor), including DNA, RNA, proteins, hormones, 
neurotransmitters and small molecules, thereby modulating important cellular and 
metabolic activities. These enzymes are classified according to the target they 
methylate like DNA methyltransferase, RNA methyltransferase, small molecule 
methyltransferase and so on.   
The first structure of AdoMet dependent methyltransferase was solved for DNA C5-
cytosine methyltransferase M.Hhai (Cheng et al., 1993). Since then many 
methyltransferase structures have been solved and characterized. Structurally, there 
are five different class of AdoMet dependent methyltransferases (Schubert et al., 
2003).  These methyltransferase exhibits enzyme analogy i.e. structurally distinct but 
catalyze the same reaction.  
Class I:  
This class of methyltransferase consist of a seven stranded β sheets 
(β3↓β2↓β1↓β4↓β5↓β7↑β6↓) and followed by α helixes on both side of sheets to make 
αβα sandwich. This fold is quite similar to the Rossmann-fold of NAD (P) binding 
domain of oxidoreducatases. The first β strands typically end in GXGXG motif (x- 
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any amino acids). The other conserved amino acid position is an acidic residue found 
at the end of β2 stand. This residue makes the hydrogen bond with ribose moiety of 
AdoMet.  Class I methyltransferase are involved in gene regulation, in protein 
expression, in mutation repairing and in DNA protection from restriction enzymes 
and so on. 
Classe II:  
This class of methyltransferase has a long central antiparallel β strand which is 
flanked by groups α helices. AdoMet bound in shallow groove and makes hydrogen 
bond with conserved RXGY motif (Dixon et al., 1996).  
Class III: 
The active site in this structural class of methyltransferase is hidden into a cleft 
between two αβα domains. Each domain contains 5 β strands and 4 α helices. Like 
class I methyltransferase, GXGXG motif occurs at C terminal of first β strands. But 
in this class of methyltransferase, this motif does not interact with AdoMet. AdoMet 
is buried between two domains in the active site.  
Class IV: 
This family consists of SPOUT family (SpoU and TrmD families) of RNA 
methyltransferase.  They found to contain 1) six stranded parallel β sheet which is 
flanked by seven α helices, 2) active site is located close to the subunit interface of 
homodimer. Residues from both the monomers form the active site region.  
Class V: 
This family is known as SET (Su(var)3-9, Enhancer of Zeste, Trithorax) -domain 
proteins . Several proteins from this family shown to methylate lysine in flexible tails 
of histones or in Rubisco (Ribulose-1,5-bisphosphate carboxylase oxygenase). 
Structurally, this family consist of a series of 8 curved β strands forming 3 small 
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sheets.   
The example and structure of each class of methyltransferases discussed above are 
shown in figure 1.3. Structural and sequence alignment data may enable the 
identification of similarities of structure and sequence conservation. Several structural 
features and sequence conservation separates small and macromolecule 
methyltransferases.  
 
1.1.2 Macromolecule versus small molecule methyltransferase 
Sequence analysis of small molecule methyltransferases suggests that they share a 
sequence identity of 15–20%. However the structural comparison showed that they 
share similarity more than the core Rossmann fold. Methyltransferases typically 
consist of well-conserved AdoMet-binding domains responsible for cofactor binding 
and methylation; and a second highly variable substrate-binding domain responsible 
for the substrate binding.  The substrate binding domain varies in shape and size to 
accommodate the different substrate and is also indicative of the group to which these 
proteins belong to.  Most of the macromolecular methyltransferase like DNA, RNA 
or proteins methyltransferase are found to contain substrate binding region as separate 
domain. These macromolecule methyltransferase are supplemented with additional 
substrate binding domain. In addition to the core Rossman fold, the macromolecular 
methyltransferase found to have major modification in the form of additional 
secondary structure element at C terminal. These two major structural features are 
found to be absent in small molecules methyltransferases. However, majority of small 
molecule methyltransferase has additional amino acids at N terminal region in the 
form of two α helices. Many small molecule methyltransferase   have an active site 
cover formed by several core fold inserts. Small molecule methyltransferase also 
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found to have insertions between β5 and α7; and β6 and β7.  These structural features 
can be used as an aid to distinguish  the macromolecule and small molecule 
methyltransferase (Martin & McMillan, 2002).  
 
1.1.3 Functional role of methyltransferases  
Methylation reactions are very important for maintenance of life. Methyl transfer is 
an important biochemical reaction in the metabolism pathway of many drugs and 
xenobiotic compounds.  For example, biosynthesis of endogenous compounds such as 
epinephrine which is a hormone and a neurotransmitter involves methylation of the 
primary distal amine of noradrenaline in a reaction catalyzed by phenylethanolamine 
N-methyltransferase (Goodall & Kirshner, 1958). N-, O-, and S-methylation have 
been reported to occur in many drugs. Some methylation reactions may terminate 
biological activity of the compounds.  
DNA methylation plays an important role in gene transcription, gene expression, gene 
activation, and mutation repair in the cells. Methylations influence the gene 
expression by affecting the interactions between DNA and chromatin proteins as well 
as specific transcription factors. In addition, it has been noted that during 
development, tissue-specific genes undergo demethylation in their tissue of 
expression. Further, the X chromosome inactivation during development is 
accompanied by de novo methylation (Razin & Cedar, 1991). DNA methyltransferase 
binds to the DNA helix by base flipping and catalyzes the transfer of the methyl 
group to adenosine and cytosine (Cheng & Roberts, 2001). In 
addition, adenosine or cytosine methylation is part of the restriction modification 




Figure 1.3: 3-Dimensional structure of five classes of AdoMet-dependent 
methyltransferase. In each class a representative structure and topology diagram is 
given.  A) class I: enzyme M.HhaI (PDB code-6MHT), B) class II: reactive domain 
of methionine synthase (PDB code -1MSK), C) class III: the bilobal structure of CbiF 
(PDB code – 1CBF), D) class IV: enzyme Yibk (PDB code – 1MXI), and E) class V: 
histone lysine N-MTase family (PDB code – 1O9S). The figure adapted from 
(Schubert et al., 2003).   
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Post translational modification of proteins in form of methylation is very common 
phenomenon in eukaryotes. Protein methylation typically takes place on arginine, 
lysine, histidine, glutamine, and asparagine amino acid residues in the protein 
sequence.  Protein methylation has been most-studied in the histones catalyzed by 
enzymes known as histone methyltransferases. Histones that are methylated on 
certain residues can act epigenetically to repress or activate gene expression (Grewal 
& Rice, 2004). In protein O-methylation forming methyl esters on carboxyl groups 
are reversible and can modulate the activity of the target protein. N-methylations 
occurring on nitrogen atoms in N-terminal and side-chain positions are generally 
irreversible. These methylation reactions can modify the amino acid residues in 
protein and thus property as well as function of a protein (Clarke, 1993).  The 
calcium-binding protein calmodulin (CaM) which regulates the activity of several 
enzymes by Ca2+ signal, undergoes N-methylation as one of the several post-
translational modifications (Cobb and Roberts 2000). Methylation alters the function 
of CaM in vivo, and affects the regulation of nicotinamide adenine dinucleotide 
kinase and other enzymes.  The part II of this thesis is discussing about the CaM and 
its interactions with neuron specific substrate proteins Ng/Nm, a different functional 
aspect of CaM  
 
1.1.4 Antibiotic resistance and methyltransferase 
Methyltransferases have been implicated to induce the antibiotic resistance of host 
cell.  Antibiotic-producing bacteria protect themselves from the toxic effects of 
antibiotics by employing methyltransferase to methylate specific ribonucleotides in 
antibiotic-binding sites of the ribosome. Methylation of the 30S ribosomal subunit 
RNA (16S rRNA) is a significant mechanism of resistance to ribosome-targeting 
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antibiotics.  Methylation of riboneucleotide shown to interfere the antibiotic binding 
without much interference with other functions of the ribosome (Poehlsgaard & 
Douthwaite, 2005). The 16S rRNA resistance methyltransferases act at 
riboneucleotide in close proximity to their respective antibiotic binding site and thus 
the sterically methyl group addition blocks antibiotic binding. For instance, two 
families of AdoMet-dependent aminoglycoside-resistance methyltransferases act 
upon 16S rRNA to produce either an N7-methyl G1405 (m7G1405) or N1-methyl 
A1408 (m1A1408) modification. The resistance spectrum conferred by m7G1405 is 
limited to the 4,6-DOS aminoglycosides (e.g. kanamycin and gentamicin). The 
m1A1408 modification confers a broad resistance spectrum that includes examples of 
the 4,6-DOS (e.g. kanamycin but not gentamicin) and 4,5-DOS aminoglycoside 
groups and also apramycin (Husain et al., 2011, Husain et al., 2010, Macmaster et al., 
2010).  
The bacterial species from genera Bacteroides are shown to be resistant to a wide 
variety of antibiotics including β-lactams, aminoglycosides, 
erythromycin and tetracycline. Resistance to multiple antibiotics has been increasing 
in Bacteroides species for decades (Vedantam, 2009). This high level of antibiotic 
resistance has prompted concerns that Bacteroides species may become a reservoir 
for resistance in other, more highly-pathogenic bacterial strains. For this thesis work 
we have selected two methyltransferase from two different Bacteroides bacteria.   
1.2 Bacteroides 
The genus Bacteroides is consisting of Gram-negative, non-endospore-
forming, anaerobes, and rod-shaped bacteria bacillus bacteria. Some of the species are 
motile and some are non-motile.  Furthermore, Bacteroides species also stimulates 
the gut lining to produce fucosylated glycans, angiogenesis (formation of blood 
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vessels) in the newborn epithelium, enhancing human uptake of nutrients. So the 
Bacteroides bacteria live in symbiotic relationship with the human host (Figure 1.4).  
Bacteroides were described in 1898 for the first time (Veillon, et al 1898).  
Bacteroides membranes contain sphingolipids which is not found in any other 
bacterial membrane. Some bacteroides also contain meso-diaminopimelic acid in 
their membrane.    
 
 
Figure 1.4: Common sites (    ) of Bacteroides and other anaerobic bacterial 
infections human. Adapted from Anaerobic Infections in Humans by Sydney M. 
Finegold Academic Press Inc. 1989.  
 
Bacteroides are commonly found in the human intestine where they have a symbiotic 
host-bacterial relationship with humans, but are also found to be  opportunistic 
pathogens (McCarthy et al., 1988). Roughly, 1010-1011 cells per gram of human feces 
have been reported.  The Bacteroides bacteria show  resistance towards different 
antibiotics such as clindamycin, chloramphenicol, carbenicillin, lincomycin and 
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tetracycline (Bodner et al., 1972,Rashtchian, 1982 #551).  They are involved in 
digesting the otherwise non digestible food items and producing valuable nutrients 
and energy that the human body needs. Their main source of energy 
is polysaccharides from plant sources but whenever available they also can use simple 
sugars. They are also found to be involved in fermentation of carbohydrates, 
nitrogenous substances, and biotransformation of bile acids and other steroids. Hence 
Bacteroides are also classified as saccharolytic meaning that they obtain carbon and 
energy by hydrolysis of carbohydrate molecules(McCarthy et al., 1988). They are 
mainly involved in degradation of polysaccharides from plant fibers, such as 
cellulose, xylan, arabinogalactan, and pectin, and vegetable starches such as amylose 
and amylopectin. Bacteroides are also known to produce several exoenzymes like 
DNAse, collagenase, neuraminidase, heparinase and some proteases. These enzymes 
assist the bacteria in the invasion of host tissues. 
Since Bacteroides species colonize in the gut, they offer help to the host by excluding 
potential pathogens from colonizing in the gut. Although Bacteroides species are 
anaerobic, they are aerotolerant and thus can survive in the abdominal cavity (Xu et 
al., 2007). However, if the other parts of the body (including the central nervous 
system, the head, the neck, the chest, the abdomen, the pelvis, the skin, and the soft 
tissues) get infected by Bacteriodes, they can cause or exacerbate abscesses and other 
infections (Xu et al., 2003). Their entry into the host involves the following steps- 
disruptions of the intestinal wall, bacterial flora infiltrate the cavity, gram negative 
aerobes e.g. E. coli initiate the preliminary tissue destruction and reduces the 
oxidation-reduction potential of the oxygenated tissue which favors the anaerobe 
growth. Finally, anaerobic Bacteroides start growing, and dominate the infection.  For 
example B. fragilis behaves like opportunistic human pathogens. It can cause 
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peritoneal cavity infection, gastrointestinal surgery, and appendicitis via abscess 
formation. Bacteroides have been known to be involved in cases of meningitis and 
shunt infections, especially in children. Hence they inhibit phagocytosis, and 
inactivate beta-lactam antibiotics. Bacteroides species are resistant to a wide variety 
of antibiotics like β-lactams, aminoglycosides, erythromycin and tetracycline (Salyers 
et al., 2004).  
Bacteroides species have an outer membrane, a peptidoglycan layer, and a 
cytoplasmic membrane. Outer membranes contain a mixture of long-chain fatty acids, 
mainly straight chain saturated, anteiso-methyl, and iso-methyl branched acids. They 
produce acetic acid, iso valeric acid, and succinic acid as their main by-products of 
their anaerobic respiration.  Some of the Bacteroides species have been shown to bind 
to polysaccharides with their outer membrane receptor system before pulling the 
polysaccharides into the periplasm for monosaccharide degradation. Their DNA-base 
composition of Bacteroides is about 40-48% G-C.  
Ability of Bacteroides bacteria to process the complex molecules into simpler 
compounds make them to play very important role in the ecosystem. The complex 
molecules degradation into simple molecule makes them to usable by the human host 
as well as the Bacteroides.  
Physiological analysis of Bacteroides showed considerable heterogeneity in terms of 
to their biochemical properties. Based on the several  phylogenetic analysis 
techniques like physiological characteristics, serotyping (Lambe, 1974), 
bacteriophage typing (Booth et al., 1979), lipid analysis (Miyagawa et al., 1978), 
oligonucleotide cataloging, and 5S - 16S rRNA sequence comparisons (Paster et al., 
1994, Weisburg et al., 1985),  the original Bacteroides members have been 
partitioned into three genera: Bacteroides (Shah & Collins, 1989), Prevotella(Shah & 
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Collins, 1990), and Porphyromonas (Shah & Collins, 1988) (Figure 
1.5). The Bacteroides are found predominantly in the colon of mammals, while 
the Prevotella and Porphyromonads generally are associated with the oral cavity and 
rumen.  
This classification restricts the Bacteroides to ten species: B. fragilis, B. 
thetaiotaomicron, B. vulgatus, B. ovatus, B. distasonis, B. uniformis, B. stercoris, B. 
eggerthii, B. merdae, and B. caccae.  
For this study, we have selected the two species- B. thetaiotaomicron VPI-5482 and 
B. vulgatus ATCC 8482. The AdoMet dependent methyltransferase BT_2972 (B. 
thetaiotaomicron VPI-5482) and BVU_3255 (B. vulgatus ATCC 8482) sequence 
analysis showed that they are involved in methylating the intermediates (2-
polyprenyl-6-hydroxyphenol and 2-polyprenyl-3-methyl-5-hydroxy-6-methoxy-1, 4-
benzoquinone) of Ubiquinone biosynthesis pathway. To the extent of our 
understanding there is no report as yet showing BT_2972 and BVU_3255 confer any 
antibiotic resistance. In the next section, we discuss about the 






Figure 1.5: Phylogenetic tree of Eubacteria based on 16s rRNA sequence 
comparisons. The evolutionary relationships between prokaryotic phyla are shown. 
Branch lengths on the tree represent evolutionary distance. Adapted from (Weisburg 
et al., 1985) 
 
 
1.3 Ubiquinone biosynthesis pathway  
Quinones are widely distributed in nature. They are best known as lipid-soluble 
components of membrane-bound electron transport chains, but in animal cells 
ubiquinone is found not only in the inner mitochondrial membrane but also in the 
endoplasmic reticulum, Golgi apparatus, lysosomes, peroxisomes, and in the plasma 
membrane. This distribution suggests that ubiquinones may be involved in a number 
of biological processes beyond the respiratory electron transport. Bacterial respiratory 
quinones can be divided into two groups. The first one comprises a benzoquinone 
termed ubiquinone or coenzyme ubiquinone. The second group contains 
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naphthoquinones – menaquinone and demethylmenaquinone (DMK) (Meganathan, 
2001). In this study the ubiquinone is more relevant and we discuss this in detail.  
The isoprenoid quinone ubiquinone (coenzyme Q, Figure 1.6) is an essential 
component in the respiratory electron transport chain of both eukaryotes and most 
prokaryotes, with the exception of the gram-positive bacteria and the blue-green algae 
(cyanobacteria). Chemically, ubiquinone is a 1,4-benzoquinone consist of 












Figure 1.6: Chemical structure of Ubiquinone (Coenzyme Q).   
 
Animal cells synthesize only ubiquinone, but MK is obtained from the diet. Most 
Gram-positive bacteria and anaerobic Gram-negative bacteria contain only MK, 
whereas the majority of strictly aerobic Gram-negative bacteria contain exclusively 
ubiquinone. Both types of isoprenoid quinones are found only in facultative anaerobic 
Gram-negative bacteria. Archaea bacteria lack ubiquinone. A nearly complete set of 
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orthologs of the ubiquinone biosynthesis genes is apparent in all cyanobacterial 
genomes, in spite of the apparent absence of ubiquinone in these organisms. The 
possibility for these genes to be involved in plastoquinone (rather than ubiquinone) 
biosynthesis in cyanobacteria has been proposed. The biosynthesis of ubiquinone is 
studied in great detail in bacteria and yeast but only to a limited extent in animal 
tissues (Meganathan, 2001).   
The biosynthesis of ubiquinone and menaquinone begins in shikimate pathway via 
chorismate in bacteria or tyrosine in higher eukaryotes. Here we focus the ubiquinone 
biosynthesis in the bacteria (Figure 1.7). The biosynthesis of ubiquinone includes at 
least nine reactions. The benzene ring derived from chorsimate intermediate of 
shikimate pathway. The prenyl side chain of ubiquinone is derived from prenyl 
diphosphate and methyl groups are derived from AdoMet.  The first committed step is 
the formation of 4-hydroxybenzoate from chorismate in a reaction catalyzed by ubiA 
enzyme. Three hydroxylation reactions introduce hydroxyl groups at positions C-6, 
C-4, and C-5 of the benzene ring of ubiquinone. They are catalyzed by ubiB, ubiH, 
and ubiF enzymes respectively. Ubiquinone synthesis requires two O methylation 
steps and one C methylation. The C-methylation reaction is catalyzed by UbiE 
methyltransferase and O-methylation reaction is catalyzed by UbiG 
methyltransferase. The same O-methyltransferase with dual specificity (UbiG) 
catalyzes both O-methylation steps in ubiquinone biosynthesis(Poon et al., 1999). 
Thus ubiquinone biosynthesis pathway involved two methyltransferase encoded by 
UbiE and UbiG gene (Figure 1.7). 
In summary, the adult human intestine is dominated by the Bacteria from the genus 
Bacteroides. In general Bacteroides habitats in symbiotic relationship, but are also 
found be opportunistic pathogens. The Bacteroides bacteria show the antibiotic 
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resistance for different antibiotics such as clindamycin, chloramphenicol, 
carbenicillin, lincomycin and tetracycline. However, the protein under study 




Figure 1.7: The schematic representation of the proposed biosythesis of ubiquinone 
in bacteria. There are two methylation reactions in the pathway catalyzed by UbiE 
and UbiG (shown by dotted ellipsoid). This figure is prepared based on the literature 
with possible intermediates and possible enzymes involved in this biosynthesis 




1.4 Aims and Objective  
In this study we have selected two methyltransferase from Bacteroides bacteria B. 
thetaiotaomicron   VPI-5482, and B. vulgatus ATCC 8482. Complete genome 
sequence of these two species are available (Xu et al., 2003, Xu et al., 2007). B. 
thetaiotaomicron   VPI-5482 genome is 6.26-Mb long while that for B. vulgatus 
ATCC 8482 is 5.3 MB. The target methyltransferase BT_2972 (B. thetaiotaomicron 
  VPI-5482) and BVU_3255 (B. vulgatus ATCC 8482) are class 1 AdoMet dependent 
methyltransferase. Sequence identity between these two enzymes is 59% which 
indicates that these two enzymes are evolutionary related. Based on the sequence 
analysis we proposed that these two enzymes catalyze the two O-methylation 
reactions in the ubiquinone biosynthesis pathway. The objective of this study is to 
understand the structure and function of these two MTases through the following 
experimental approaches- 
1. To clone the gene BT_2972 and BVU_3255 into the expression vector 
followed by protein expression and purification.   
2. Biophysical characterization of the recombinant proteins using different 
techniques like mass spectrometry analysis, peptide mass finger printing, size 
exclusion chromatography and Dynamic light scattering (to access the 
oligomeric state of the protein).  
3. Isothermal calorimetric analysis to characterize the thermodynamics of ligand 
(SAM and SAH) binding. 
4. To determine the Apo and complex structures of these proteins with ligands   
(AdoMet/SAM and AdoHcy/SAH) using X-ray crystallography.  
5. Structure function analysis to understand the role of these enzymes in 
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The adult human intestine is dominated by bacteria from the genus Bacteroides. In 
general Bacteroides habitats in symbiotic relationship, but are also found to be  
opportunistic pathogens (McCarthy et al., 1988).  The Bacteroides bacteria show  
resistance towards different antibiotics such as clindamycin, chloramphenicol, 
carbenicillin, lincomycin and tetracycline (Bodner et al., 1972,Rashtchian, 1982 
#551). Recently, the complete genome of two species B. thetaiotaomicron VPI-5482 
and B. vulgatus ATCC 8482 of  the genus Bacteroides has been sequenced (Xu et al., 
2007, Xu et al., 2003). An open reading frame (ORF) in the chromosomal genome of 
B. thetaiotaomicron VPI-5482 encodes a putative methyltransferase BT_2972 
(accession no NP_811884.1). Similarly BVU_3255 (accession no. YP_001300506.1) 
is a putative methyltransferase from B. vulgatus ATCC 8482. Previously the apo 
structure of BT_2972 (pdb code 3F4K) and BVU_3255 (pdb code 3E7P) and  that of 
a closely related protein Q5LES9_BACFN-SAM complex (pdb code 3KKZ) from 
B.fragilis NCTC 9343 had been determined by Northeast Structural Genomics 
consortium, but not yet reported in the literature. Towards understanding the structure 
and function of these two homologous (sequence identity 59%) methyltransferases, in 
this chapter we report the cloning, protein expression and biophysical characterization 
of BT_2972 and BVU_3255. Besides, both the proteins were crystallized in the apo 
form and as complex with ligands such as SAM and SAH. The sequence analysis 
suggests that both BT_2972 and BVU_3255 are small molecule methyltransferase 





2.2 Materials and Methods 
2.2.1 Cloning  
Gene encoding the BT_2972 (gene ID 1075985) and BVU_3255 (gene ID 5304216) 
were chemically synthesized (GeneScript, USA) and inserted into pUC57 cloning 
vector. Subsequently, to clone them into the expression vector, these genes were 








Forward: 5’ CTTTCATATGCATCATCATCATCATCATAATAATGAC ’3 
Reverse: 5’ CTTTCTCGAGTCACCTTCTCAGTGAGAATCC’3 
 
This PCR amplification introduced Nde1 and Xho1 restriction sites at 5’ and 3’ end 
of each gene respectively.  This also resulted in the introduction of Met start codon 
followed by 6 His codon at 5’ end of each gene. Both the PCR products were gel 
purified and then digested with Nde1 and Xho1 (NEB, England) along with vector 
pGS21a (GeneScript, USA). The digested gene products were ligated with pGS21a 
vector and transformed into E.coli DH5α cells. Positive colonies were selected based 
on colony PCR and sequence of insert was verified by DNA sequencing. 
 
2.2.2 Expression and purification 
For large scale protein expression, recombinant plasmid pGS21a-BT_2972 and 
pGS21a-BVU_3255 were transformed into chemically competent E. coli BL21 (DE3) 
cells. A single colony was chosen to inoculate 100 ml of the LB media containing 
100µg/ml ampicillin and this was incubated overnight at 37 0C with continuous 
shaking. 50 ml of this overnight grown culture was used to inoculate 1 L of the LB 
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media which was allowed to grow at 37 0C till the OD600 attained 0.6-0.8 AU.  The 
culture was then induced with 0.15 mM IPTG and further allowed to grow for 16 hrs 
at 16 0C. The cells were harvested by centrifugation at 9800 g for 10 min.  
Cell pellets were re-suspended in 100 ml of lysis buffer composed of 50 mM Tris–
HCl (pH 7.4), 500 mM NaCl, 10% v/v glycerol, 20 mM imidazole, and 20 mm BME. 
Cell suspension was sonicated for 5 min at 28% amplitude and an ON/OFF 1 second 
pulse in Vibra-Cell VCX750 ultrasonic processor using 13 mm probe (Sonics). The 
cell lysate was centrifuged at 39000 g for 30 min at 4 0C to remove the cell debris and 
the insoluble proteins. The clear supernatant was mixed with 5 ml of Ni–NTA 
(Qiagen) resin pre-equilibrated in lysis buffer and kept for binding at 4 0C for 2 hrs. 
After binding, the supernatant was removed and the Ni–NTA resin was washed 
thrice, using 10 ml of lysis buffer each time, with a 15 min. interval. After washing, 
the bound proteins were released from Ni-NTA beads using lysis buffer 
supplemented with 300 mM imidazole.  As a next step of purification, the BT_2972 
and BVU_3255 fractions  collected from Ni-NTA beads were  passed through the gel 
filtration column- HiLoad™ 16/60 Super- dex™ 200 prep grade (Amersham 
Biosciences, Sweden). The column was pre-equilibrated with a buffer consisting of 
20 mM Tris–HCl (pH 7.4) and 200 mM NaCl. Gel filtration chromatography was 
performed at 4 0C using the AKTA FPLC. Protein quantification was done by 
Bradford method (Zor & Selinger, 1996) using reagent from BioRad (USA).  
 
2.2.3 Dynamic light scattering 
Fractions of individual proteins from the gel filtration chromatography were pooled 
together and concentrated to 10 mg/ml.  Homogeneity of each of the concentrated 
proteins was checked by Dynamic Light Scattering (DLS) using a DynaPro 
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instrument (Protein Solutions, USA). All samples were centrifuged at 10000 g for 20 
min before the experiment. The measurements were carried out at 25 0C. The 
software provided by the manufacturer was used to calculate the hydrodynamic 
properties of BT_2972 and BVU_3255. 
 
2.2.4 Crystallization  
BT_2972 and BVU_3255 at a concentration of 10 mg/ml were mixed with 
SAM/SAH (ratio 1:5 protein: ligand) which is well above the micro molar binding 
affinity indicated by preliminary calorimetry experiments (results not shown) for 
making their respective complexes. Proteins and SAM/SAH were kept in a buffer 
consisting of 20 mM Tris–HCl (pH 7.4) and 200 mM NaCl.  Crystallization trials 
were performed for apo, SAM and SAH complex of each of the proteins. 
Crystallization experiments were performed manually by hanging drop vapour 
diffusion method at room temperature.  Typically 1µl of protein and 1µl of reservoir 
solutions were mixed together and equilibrated against 500 µl of reservoir solutions. 
Initial crystallization conditions were identified from the Hampton Research screens 
(PEG/ION and PEGRx2). Further, these conditions were optimized to obtain 
diffraction quality crystals. 
 
2.2.5 Data collection 
Crystals of both the proteins and their SAM/SAH complexes were soaked briefly (30 
sec) in a cryo-protectant solution consisting of mother liquor supplemented with 10 % 
(v/v) glycerol, picked up in a nylon loop, and flash cooled at 100K in a N2 cold 
stream (McFerrin & Snell, 2002).  The complete diffraction data sets for the apo 
protein crystals were collected at the Bruker AXS X8 Proteum X-ray system  (Bruker 
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AXS Inc., Madison, USA) while that for the SAM/SAH: protein complex crystals 
were collected in the beamline X-12B1 (Quantum 4-CCD detector -Area Detector 
Systems Corp Poway, CA, USA) at the National Synchrotron Radiation Research 
Centre (NSRRC), Taiwan. A complete data set (360°) was collected for some crystals 
in the in house X-ray machine (wavelength – 1.5418 Å). Some data was collected in 
synchrotron ((wavelength – 1.000 Å). In order to utilize the beam time, minimum no 
of frames were collected. No of frames were decided based completeness (greater 
than 90 %), redundancy (more than 3) in the higher resolution shell. The data 
collection strategy such as number of images and degrees per image are provided in 
Table 2.1. The collected data sets were processed using HKL2000 (Otwinowski & 
Minor, 1997).  
 
2.3. Results 
The optimized expression of BT_2972 and BVU_3255 from the pGS21a vector gave 
high yields and resulted in approximately 200 mg of each protein in the supernatant 
from 1L cell culture (Figure 2.1A and 2.1B). BT_2972 and BVU_3255 proteins were 
purified by two chromatographic steps: - the Ni-NTA affinity chromatography 
followed by gel filtration.  Both proteins eluted at a volume which corresponded to 
the monomer size of these proteins, as compared with molecular weight standards 
(Figure 2.2). The final yield of each of the purified proteins was approximately 120 
















Figure 2.1: SDS-PAGE showing the expression and purification profile of BT_2972 
(A) and BVU_3255 (B). Lane 1- marker, lane 2- cleared lysate, lane 3- flow through 
after affinity binding, lane 4 and 5- washes of Ni-NTA beads, lane 6 and 7- elution 
from Ni-NTA beads, and lane 8 - gel filtration fraction. Affinity purified protein was 








Table 2.1: Crystallization conditions and data collection statistics  
            
aRsym = ∑|Ii – <I>|/|Ii| where Ii is the intensity of the ith measurement, and <I> is the mean intensity for 
that reflection. 
* The high resolution bin details are in the parenthesis. 
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a= 60.55  
b= 74.38   
c= 117.11   
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β = 104.61    
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c = 133.0 
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50.0 – 2.8 
(2.9-2.8) 
50.0 - 2.4 
(2.49-2.4) 
50.0 - 2.3 
(2.38-2.3) 
50.0 - 2.9  
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50.0 - 2.2 ( 
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95.3 (74.7) 94.7 (73.1) 93.5(86.0) 92.8 (74.5) 94.7 (68.0) 95.6( 91.4) 
Overall (I/ σ (I) 4.1 9.9 10.2 23.3 15.0  15.4 
Rsyma  0.110 (0.185) 0.059 (0.200) 0.074 
(0.215) 




The purified proteins were concentrated upto 10 mg/ml. Size homogeneity of the 
proteins was monitored by dynamic light scattering experiments (Figure 2.3) during 
concentration and prior to crystallization.  This showed the molecular weights to 
correspond to the monomers in solution and consistent with the gel filtration 
observations.   
Additionally, the identity of the purified proteins, BT_2972 and BVU_3255, was 
verified by the peptide mass fingerprinting (PMF) experiments (data not shown).  In 
both the proteins PMF detected peptide from C-terminal and Ni-NTA binding 
indicated the presence of His tag at N-terminus. This suggests that there was no 




Figure 2.2: Gel filtration chromatography elution profile of BT_2972 (dotted line) 
and BVU_3255 (solid line).  Elution profile of molecular weight standard is shown as 
dashed line and marked with different size of proteins (kDa). Gel filtration profile 
shows both proteins elute as monomer. 
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The noncleavable His tagged proteins were used for crystallization. The crystals 
appeared after 2 days and grown upto 7 days and have crystallized in different space 
groups. The collected data sets were processed to a maximum possible resolution 
with acceptable redundancy; completeness and Rsym in highest resolution bin (Figure 
2.4). The Vm calculation indicated the presence of 2 molecules in the asymmetric 
unit of apo BT_2972, its SAM/SAH complexes and in apo BVU_3255, whereas 4 
molecules in the asymmetric unit of BVU_3255 complexed with SAM/SAH (Table 
2.1). Further this is confirmed by the self-rotation function calculations.  Notably, 
while we were in the data collection stage, the apo structures of both proteins 
BT_2972 (3F4K) and BVU_3255 (3E7P) were available in the pdb data base and 




















Figure 2.3: Dynamic light scattering histogram of BT_2972 (A) and BVU_3255 (B). 




The BT_2972 structures (apo, SAM and SAH complexes) and 3F4K all crystallized 
in three different space groups. In the case of   BVU_3255 all of our structures and 
3E7P were crystallized in different orthorhombic space groups.  Our structures were 
crystallized in P21212 (Andreasen et al.) and P212121 (SAM/SAH), whereas 3E7P was 
in I222. Similarly a closely related SAM-dependent methyltransferase from B.fragilis 
was crystallized (in complex with SAM) in space group C2. The structure of both 
proteins and their complexes was determined by molecular replacement method using 
the program Molrep-auto MR in CCP4 suite (Vagin & Teplyakov, 2010). The 
structure solution clearly indicated the expected number of molecules in the 
asymmetric unit of BT_2972 and BVU_3255 with the initial R-factors in the range of 
0.39 to 0.42. The models were refined using CNS (Brunger et al., 1998). The non 
crystallographic symmetry (NCS) was used during the refinement. When the R-
factors were close to 30s the difference maps were calculated and clearly showed the 
presence of the ligands.  
The PISA server (Krissinel & Henrick, 2007) showed that the symmetry related 
molecule of 3F4K and 3E7P can form the dimer with complexation score 1. All 
BT_2972 and apo BVU_3255 crystals showed two molecules in the asymmetric unit 
with a similar dimer interface region as predicted for 3F4K and 3E7P. Similarly 
SAM/SAH complexes of BVU_3255 with 4 molecules in the asymmetric unit have a 
similar dimer interface region. The observed common dimer interface suggests that 
































Figure 2.4: Representative diffraction pattern of both proteins crystals BT_2972-





In summary, this chapter reports the expression, purification, crystallization (of apo 
as well as SAM/SAH complexes), data collection and diffraction analysis of the 
methyltransferase BT_2972 and BVU_3255. These studies lead to the determination 
of the first representative methyltransferase structure in complex with SAM/SAH 
from the respective Bacteroides bacteria. Sequence analysis  of these two proteins 
suggest that both are homologous with similar SAM/SAH binding regions and are 
small molecule methyltransferase involved in methylating the intermediates of 
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Methyltransferases (EC 2.1.1) comprise a group of approximately 140 
transferase enzymes that catalyze the transfer of a methyl group from a universal 
donor molecule, such as S-adenosyl-L-methionine (AdoMet), to a target substrate 
acceptor molecule, such as DNA, RNA, protein, lipid, or other small molecules. 
These enzymes play a crucial role in numerous biochemical processes, including 
signal transduction, biosynthesis, metabolism, protein modification, gene silencing, 
and chromatin regulation (Martin & McMillan, 2002, Miller et al., 2003). 
Methyltransferases are structurally categorized into 5 classes (I-V). Whilst class I 
methyltransferases differ in their overall structure and substrate binding domain, all of 
the AdoMet-dependent methyltransferases in class I share a common Rossmann-fold 
at their catalytic site (Bujnicki, 1999).  
Bacteroides thetaiotaomicron is a gram-negative anaerobic bacterial pathogen 
with extreme disease-causing potential and antibiotic resistance. Predominantly found 
in the human intestinal tract (Xu et al., 2003), these bacteria dominate over other 
bacterial species and are involved in the uptake and degradation of otherwise non-
digestible polysaccharides (e.g. amylose, amylopectin and pullulan), as well as in 
capsular polysaccharide biosynthesis, environmental sensing, signal transduction and 
DNA mobilization (Bjursell et al., 2006, Xu et al., 2003). The complete genome of 
the strain B. thetaiotaomicron VPI-5482 has been sequenced (Xu et al., 2003) and an 
open reading frame (ORF) encodes a protein BT_2972 (accession no NP_811884.1) 
that is predicted to have a conserved AdoMet binding domain, which is a 
characteristic of most methyltransferases (Loenen, 2006).  
As a continuation of our studies toward understanding the structure and 
function of methyltransferases, in this chapter we report the crystal structures of 
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BT_2972, and the thermodynamics of AdoMet/AdoHcy binding with BT_2972. This 
study revealed significant conformational changes to a loop in the region of the active 
site (Glu121–Ile127), resulting in open and closed forms of the active site. In 
addition, our analysis combined with literature suggests that BT_2972 is a small 
molecule methyltransferase, and may be involved in catalyzing the O-methylation 
reaction in the ubiquinone biosynthesis pathway.   
 
3.2 Material and Methods 
3.2.1 Cloning and protein purification  
The BT_2972 gene was cloned into expression vector pGS21a (GeneScript, 
USA) and the recombinant plasmid was transformed into E. coli BL21 (DE3) 
competent cells. The protein was purified to homogeneity using a two-step procedure 
involving Ni2+-NTA affinity (Hengen, 1995) and gel filtration chromatography in a 
buffer consisting of Tris-HCl (pH 8.0) and 200 mM NaCl.  Prior to crystallization, the 
homogeneity of BT_2972 was verified by dynamic light scattering (DLS) 
experiments.  A detailed cloning, expression and purification procedure is described 
in chapter 1. 
 
3.2.2 Crystallization and structure determination  
Diffraction quality crystals of apo BT_2972 were obtained from a reservoir 
solution consisting of 0.12 M magnesium acetate and 16% (w/v) PEG3350, while the 
crystals of AdoMet and AdoHcy complexes were each grown from 25% (v/v) 2-
propanol, 0.1 M MES monohydrate (pH 6.0) and 18% (w/v) polyethylene glycol 
monomethyl ether 2,000, respectively. Crystals were cryo-protected with 10% 
glycerol supplemented with reservoir condition and flash cooled in N2 cold stream at 
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100 K (McFerrin & Snell, 2002). A detailed crystallization screening, crystal 
optimization and data collection strategy is given in chapter 2.  
The molecular replacement method was used to solve the structure of 
BT_2972 using the program Molrep-auto MR in CCP4 suite (Vagin & Teplyakov, 
2010) using 3F4K as the search model. The molecular replacement solution clearly 
indicated the expected number of molecules in the asymmetric unit of BT_2972, 
predicted based on the Matthew’s constant. The initial R-factors of the unrefined 
models were in the range of 0.39–0.42 with a correlation coefficient of ~0.6. When 
required, protein models were manually built  using the program COOT (Emsley & 
Cowtan, 2004) and refinement performed using the program CNS (Brunger et al., 
1998).  Difference maps were calculated to position the ligands. At the final stage of 
the refinement, well-ordered water molecules were included. The models have good 
stereochemistry, with all residues within the allowed region of Ramachandran plot as 
analyzed by PROCHECK (Laskowski et al., 1993). All structure-related figures 
reported were generated using PyMol (DeLano & Lam, 2005). 
 
3.2.3 Isothermal titration calorimetry    
The binding of AdoMet and AdoHcy to BT_2972 was studied using 
isothermal titration calorimetry (Pierce et al., 1999). Protein and stock solutions of 
AdoMet and AdoHcy were kept in a buffer consisting of 20 mM Tris-HCl (pH 8.0) 
and 200 Mm NaCl. The ITC experiments were performed using a VP-ITC 
calorimeter (Microcal, LLC) at 24oC with 0.4 ml of AdoMet or AdoHcy in the 
injector cell and 1.8 ml of protein in the sample cell.  All samples were thoroughly 
degassed and centrifuged to remove precipitates. 10 µl injection volumes were used 
for all experiments. Two consecutive injections were separated by 5 min to reset the 
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baseline. The control experiment, consisting of titration of AdoMet/AdoHcy against 
buffer, was performed and subtracted from each experiment to adjust for the heat of 
dilution of ligands. ITC data were analyzed with a single site fitting model using 
Origin 7.0 software (OriginLab Corp.).  
 
3.2.4 PDB deposition  
The coordinates and structure factors of apo, AdoMet and AdoHcy with 
BT_2972 complexes were deposited in the RCBS database (Bernstein et al., 1977) 
with the access code 3SVZ, 3SXJ, and 3T0I, respectively. 
 
3.3 Results 
3.3.1 BT_2972 Sequence Analysis  
A PSI-BLAST (Altschul et al., 1997) search on BT_2972 sequence indicated 
that it belongs to the AdoMet-dependent methyltransferase family, with 80% and 
51% sequence identity to two methyltransferases involved in the 
ubiquinone/menaquinone biosynthesis pathways of Bacteroides xylanisolvens XB1A 
(score = 259) and Gordonibacter pamelaeae 7-10-1-b (score = 266), respectively. 
The PSI-Blast e-score indicates that these two sequences are evolutionarily related to 
BT_2972. Sequence alignment of the cluster of orthologous groups (COG) of similar 
ubiquinone/menaquinone methyltransferase (COG2226H) revealed several conserved 
residues (Tatusov et al., 2000) (Figure 3.1).  These analyses suggest that BT_2972 
may be involved in the biosynthesis of ubiquinone/menaquinone; these pathways 







Figure 3.1: Multiple sequence alignment of BT_2972 with selected sequences of 
methyltransferase of ubiquinone/menaquinone biosynthesis pathway and mycolic 
acid modifying methyltransferases. The top five sequences (1-5) show the structure 
based sequence alignment of BT_2972 with mycolic acid methyltransferases 
(CmaA1, PDB code 1KPG; MmaA4, PDB code 2FK8; PcaA, PDB code  1L1E and 
CmaA2, PDB code 1KPI). Sequences 6-16 represent the sequence based alignment of 
BT_2972 with the ubiquinone/menaquinone methyltransferases (B. xylanisolvens - 
CBK67164.1, G. pamelaeae- CBL04788.1,  B. vulgatus -YP_001300506.1, P. 
propionicigenes- YP_004041425.1, T. lettingae -YP_001471184.1  , A. vinosum- 
YP_003442314.1, D. oleovorans -YP_001528472.1 , D. retbaense -  
YP_003197230.1, M. marisnigri- YP_001046804.1, O. terrae- YP_001818708.1,  M. 
evestigatum- YP_003726621.1). Sequence similarities are highlighted in red, whereas 
sequence identities are shown as white letters on a red background. The residues that 
interact with AdoMet/AdoHcy are marked with asterisks. The structure based 
alignment was obtained using DALI(Holm & Sander, 1995). Alignment was carried 
out using ClustalW(Chenna et al., 2003). The secondary structure for BT_2972 is 
shown on the top. This diagram was generated using the program ESPript(Gouet et 
al., 1999). Abbreviation- B: Bacteroides, G: Gordonibacter, P: Paludibacter,T: 
Thermotoga, A: Allochromatium, D: Desulfococcus, M: Methanoculleus, O: Opitutus. 
 
 
3.3.2 Structure of BT_2972 and its AdoMet/AdoHcy complexes  
   Crystal structure of the apo BT_2972 and its complex with AdoMet and AdoHcy 
were solved and refined up to a resolution of 2.9, 2.5 and 2.4 Å, respectively (Table 
3.1, Figure 3.2). The BT_2972 structures (apo, AdoMet and AdoHcy complexes) and 
the search model (PDB code 3F4K) all crystallized in three different space groups. 
BT_2972 structures crystallized with two molecules in the asymmetric unit (Table 
3.1), while 3F4K crystallized with one molecule in the asymmetric unit. Notably, 
each structure crystallized in different conditions.  
 
The pair wise comparison of these structures did not reveal any major conformational 
changes other than to the active site loop region, residues Glu121-Ile127. 3F4K is 
similar to BT_2972 apo form (RMSD 0.7Å for all Cα atoms).  Despite the presence 
of two molecules of BT_2972 in the asymmetric unit, gel filtration and Dynamic 
Light Scattering (DLS) experiments showed that they exist as monomers in solution.  
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The BT_2972 construct has a total of 257 amino acids and a (His)6-tag at the N-
terminus. In all three models, the electron density map for the first 12 amino acids 
and His-tag was not well-defined and, as such, these residues were not included in the 
model.  
      Table 3.1: Crystallographic refinement statistics 
 Native AdoMet  AdoHcy 
Refinement and quality a    
Resolution range (Å) 50.0 – 2.9 50.0 - 2.5 50.0 - 2.4 
Rworkb (no. of reflections) 0.20(8952) 0.23 (13792) 0.23(16142) 
Rfreec (no. of reflections) 0.26 (674) 0.27 (1013) 0.26(1189) 
RMSD bond lengths (Å) 0.008 0.008 0.007 
RMSD bond angles(o) 1.17 1.12 1.00 
Average B-factorsd (Å2)    
     Main chain 22.1 47.1 32.0 
     Side chain 25.2 48.2 34.4 
Ramachandran plot    
Most favored regions (%) 91.0 90.1 92.1 
Additional allowed regions (%   8.5    9.6   7.9  
Generously allowed regions (%)   0.5   0.4   0.0 
Disallowed regions (%)   0.0   0.0   0.0 
 
 
aReflections with I>σ was used in the refinement. 
bRwork = |Fobs – Fcalc|/|Fobs| where Fcalc and Fobs are the calculated and observed 
structure factor amplitudes, respectively. 
cRfree = as for Rwork, but for 5% of the total reflections chosen at random and omitted 
from refinement. 
dIndividual B-factor refinements were calculated. 















Figure 3.2: Structure of BT_2972. (A) Ribbon representation of the crystal structure 
of BT_2972-AdoMet complex. The α helices and β sheets are shown in cyan and 
magenta, respectively. The N- and C- termini and the secondary structural elements 
are labelled. The AdoMet is shown in stick representation (yellow). Stereo view of 
2Fo-Fc map of (B)   AdoMet and (C) AdoHcy in BT_2972 complexes. Map is 
contoured at a level of 1.0σ.  AdoMet is shown in yellow (B) and AdoHcy is shown 
in orange (C). Selected interacting residues from BT_2972 are shown in cyan colour.  
 
 
The BT_2972 molecule is a single domain, globular protein comprising both the 
cofactor and substrate binding site within the same domain (Figure 3.2A).  It consists 
of a total of nine α-helices and seven β-strands of different lengths that are distributed 
throughout the protein sequence. The core domain adopts a typical class I Rossmann-
like AdoMet-binding fold that is common to all class I AdoMet-dependent 
methyltransferases, comprising a seven-stranded β-sheet (β3↓β2↓β1↓β4↓β5↓β7↑β6↓) 
flanked by three α helices on both sides (Schubert et al., 2003). In this fold, all β-
strands in the active site are planner and parallel to each other, with the exception of 
the anti-parallel strand β7. The AdoMet/AdoHcy binding region is primarily located 
C 
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within the N-terminus (Figure 3.2A), while the substrate is proposed to bind to C-
terminal residues. Depending on the target for methylation, substrate binding sites of 
different methyltransferases vary in structure and size to accommodate the different 
targets.  
 
3.3.3 Thermodynamics of AdoMet/AdoHcy binding 
The interactions between BT_2972 with AdoMet and AdoHcy were studied using 
ITC (Figure 3.3). As predicted from the crystal structure, ITC experiments showed a 
single site binding model for both AdoMet and AdoHcy. The thermodynamic binding 
parameters (where Ka is the association constant, ΔH is the change in enthalpy, and N 
is the number of binding sites) were calculated from ITC data fitting, as follows: for 
AdoMet: Ka=0.395×105 M−1 (± 0.0435 × 105), ΔH=−3.775 kcal/mol (±0.42), 
N=0.78.±0.07; and for AdoHcy: Ka=3.498×105 M−1 (±0.66×105), ΔH=−18.63 
kcal/mol (±5.6), N=0.82±0.04.  Although both AdoMet and AdoHcy have similar 

































Figure 3.3: ITC profiles for BT_2972 titrated against the cofactor (A) AdoMet 
and (B) AdoHcy. The ITC control experiments: C) Titration profile for AdoMet 
against buffer. A similar figure was obtained for AdoHcy titration against 
buffer.  D) Titration of buffer against BT_2972 protein solution. The raw ITC 
data for injections of ligands into the sample cell containing the native protein 
are shown in the upper panels of ITC profiles. The peaks were normalized to the 
ligand:protein molar ratio and were integrated as shown in the bottom panels. 
Solid dots indicate the experimental data, and their best fit was obtained from a 





3.3.4 AdoMet/AdoHcy Binding Pocket of BT_2972   
BT_2972 was crystallized with and without AdoMet and AdoHcy (Figure 3.2). In the 
active site, both ligands are buried and are oriented in a similar way, with their 
adenosyl base moiety facing outside and the carboxypropyl moiety facing inside the 
molecule.  Residues located in the active site region, such as Arg25, Gln26, Gly27, 
Cys55, Gly56, Gln60 and Gly54; interact with the carboxypropyl moiety of AdoMet 
and AdoHcy in both complexes.  Similarly, residues within the region of the active 
site, such as Leu77, Met105, Asn126, Gly103, Glu121 and Gly122, interact with the 
adenosyl moiety of the ligands (Figure 3.2B and 3.2C). These residues line up in the 
active site, and all interact with the ligands either via hydrophobic or hydrogen 
bonding contacts (Figure 3.2B and 3.2C). There are ten hydrogen bonding contacts 
(<3.3Å) between the ligand and BT_2972 in both complexes. The superposition of 
these two complex structures gave an rmsd of 0.4Å. The carboxyl group of Asp76 in 
β2 strand was found to interact with the oxygen atom of the AdoMet/AdoHcy ribose 
ring. This is a conserved position with Asp or Glu in a number of methyltransferases 
and interacts with ribose ring of the bound AdoMet/AdoHcy through hydrogen 
bonding contacts (Lim et al., 2001).  
 
3.3.5 Conformational switch acts as a gate to the active site   
Superposition of the apo BT_2972 with AdoMet- and AdoHcy-bound structures gave 
a root mean square deviation (RMSD) of 1.0 and 0.8 Å, respectively, for 245 Cα 
atoms (Figure 3.4A). A large conformational change was observed between the 
residues Glu121 and Ile127 upon the binding of AdoMet/AdoHcy in the active site 
region. This region is located in the loop between β4 and α5, with Glu121, Gly122 
and Asn126 making direct contact with AdoMet/AdoHcy. Compared with the apo 
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BT_2972, the backbone atoms of the AdoMet/AdoHcy complexes of this region are 
moved approximately 9Å (with a maximum side chain movement of Ile124 by 12.4Å 
and Tyr125 by 10Å), opening up the active site (Figure 3.4B). The apo BT_2972 thus 
represents the closed form of the active site. In the apo structure, the loop Glu121-
Ile127 protrudes into the cofactor binding region, with the side chains of Ile124 and 
Tyr125 occluding the active site from engaging with cofactors (Figure 3.4C).  
However, on the other side of the active site cleft, there was no conformational 
change observed in the wall of the cleft, containing residues Leu77 and Phe81. This 
suggests that the loop region (Glu121-Ile127) acts as a flexible gate that enables the 
cofactors to enter or leave the active site region. In addition to opening the gate, this 
loop region may also enhance the hydrophobic interactions with substrate (Figure 







Figure 3.4: A) The superposition of apo BT_2972 (magenta) and BT_2972-AdoMet 
(cyan) complex. Conformational change in the fragment Glu121-Ile127 is marked by 
a rectangular box. B). A close up view of the conformational change C) 
Conformational change in the fragment Glu121-Ile127 with bound ligand (AdoMet is 
shown here).  
 
3.3.6 Structural Comparison with other Homologs 
A search for structurally similar proteins in PDB database using DALI server 
(Holm & Sander, 1995) revealed that BT_2972 shared the highest homology with 
several class I Rossmann folded methyltransferases (RFM). The most structurally 
similar protein we identified (with known function) was Hma enzyme (PDB code 
2FK8: Score 20.4 and rmsd 3.3 Å for 237 Cα atoms; sequence identity 12%), an 
AdoMet-dependent methyltransferase from Mycobacteriam tuberculosis involved in 
the production of branched chain mycolic acid (Boissier et al., 2006). Next, was 
mycolic acid cyclopropane synthase CmaA1 from M. Tuberculosis (PDB code 1KPG, 
C 
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Score 19.9 and rmsd of 3.3 Å for 232 Cα atoms; sequence identity 12%) (Huang et 
al., 2002). CmaA1 is also an AdoMet-dependent protein with a similar α/β Rossmann 
fold that is involved in site-specific methylation of the mycolic acid.  Figure 3.5A 
shows the superposition of the structure of BT_2972- AdoHcy and CmaA1-CTAB-
AdoHcy(Huang et al., 2002). We observed close alignment of the active site regions 
of these two structures with the cofactors (Figure 3.5A). The carboxypropyl portions 
of AdoMet in both proteins are in the same plane, but the ribose and adenosyl 
moieties show some deviation. This similarity in the active site suggests a similar 
substrate. To date, only one structure of an uncharacterized ubiquinone/menaquinone 
methyltransferase is available in PDB: TM1389 from Thermotoga maritima MSB8 
(Code 2AVN, Score 14.4 and RMSD 3.3 Å for 179 Cα atoms; sequence identity 
14%); this structure is not reported in the literature. Based on these analyses, we 
propose that BT_2972 belongs to the class of small molecule methyltransferases 











































Figure 3.5: A) Cα trace for the superposition of BT_2972-AdoHcy (cyan) and 
mycolic acid cyclopropane synthase CmaA1-AdoHcy-CTAB (light orange) from M. 
tuberculosis (PDB code 1KPG). AdoHcy of the two proteins occupies the same 
region in the active site. The carboxypropyl moiety is lying in same plane but ribose 
and adenosyl moieties are separated by 3.5Å.  Methylation substrate CTAB of the 
CmaA1 is shown as stick representation in yellow. The alignment was carried out in 
PyMol (DeLano & Lam, 2005). B) The proposed substrate binding region of 
BT_2972-AdoHcy is shown as yellow dotted surface. C) The inferred substrate 
binding site also is shown in surface diagram D) Similarity between CTAB and the 
proposed substrate for BT_2972:- (i) CTAB contain a 16-carbon-long alkyl chain 
with a positively charged quaternary ammonium group at one end. (ii) 2-polyprenyl-
6-hydroxyphenol and (iii) 2-polyprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-
benzoquinone; both substrate have similar 10- carbon long alkyl chain. E) 
Conformation change in the fragment Glu121-Ile127 with respect to the substrate 
binding site. Side chains of Ile124 and Tyr125 in AdoMet/AdoHcy complex structure 
project towards the substrate site and will enhance the hydrophobic interactions with 
substrate.  
 
3.3.7 Possible Substrate Binding Site and Substrate   
The superposition of CmaA1 substrate (CTAB) complex with our BT_2972 structure 
allowed us to propose the substrate binding site for BT_2972. The substrate CTAB of 
CmaA1 occupies a space that presents as a cavity in the BT_2972 complex adjacent 
to the AdoMet/AdoHcy binding site, and it is reasonable to suggest that this proposed 
substrate binding site in BT_2972 is where methylation occurs (Figure 3.5B). The 
site primarily consists of C-terminal residues and is surrounded by helices α1, α6 and 
α9 (yellow dotted region in Figure 3.5B and 3.5C) of the active site region. Most of 
the amino acids are bulky and hydrophobic in nature and therefore suitable to interact 
with a substrate of a hydrophobic nature. The substrate of CmaA1, i.e. CTAB, and the 
intermediates which undergo methylation in the ubiquinone pathway are similar, with 
long aliphatic chains (Figure 3.5D).  This suggests that substrates for BT_2972 are 2-
polyprenyl-6-hydroxyphenol and 2-polyprenyl-3-methyl-5-hydroxy-6-methoxy-1, 4-
benzoquinone; intermediates of the ubiquinone pathway.  In addition to the aliphatic 
chains, BT_2972 substrate has a benzene ring (Figure 3.5D).  The hydrophobic 
environment and shape of the proposed substrate binding site of BT_2972 could 
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potentially form a hydrophobic cluster with the incoming substrate.  Moreover, upon 
an open conformation, the loop (Glu121-Ile127) that is located between the 
AdoMet/AdoHcy binding site and the proposed substrate binding site will enhance 
the hydrophobic interactions with the bound substrate by bringing its own 
hydrophobic residues (Ile124 and Tyr125) closer to the substrate (Figure 3.5E).  
The sequence alignment shows that the AdoMet/AdoHcy binding residues are strictly 
conserved in all of the compared sequences, and suggests that the AdoMet/AdoHcy 
binding site will be the same in all the remaining 11 proteins whose structures are not 
known (5 structure-based and 11 sequence-based alignments, outlined in Figure 3.1).  
Notably, the confirmed substrate binding site of CmaA1 and the proposed substrate 
binding site for BT_2972 are conserved.  Moreover, this proposed substrate binding 
site in BT_2972 is close to the transferable methyl group of AdoMet, indicating that it 
fulfils the geometric requirements for methylation SN2 reactions: a linear and planar 
arrangement of the acceptor substrate atom, the transferred methyl group and the 
sulphur atom of AdoMet to form the appropriate transition state. However, the 
proposed substrate warrants further experimental verification. 
 
3.4 Discussion 
Class I AdoMet-dependent methyltransferases consist of a well-conserved AdoMet-
binding region that is responsible for cofactor binding and methylation and a highly 
variable substrate-binding region (Kozbial & Mushegian, 2005).  Macromolecule and 
small molecule methyltransferases have several distinguishing features in addition to 
their core Rossmann fold. Macromolecular methyltransferases have additional 
secondary structural elements at their C terminus (Martin & McMillan, 2002) and in 
most cases, their substrate binding region is a separate domain to engage with the 
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substrate such as  DNA, RNA or proteins. In contrast, small molecule 
methyltransferases lack these two major structural features, with the majority having 
two additional α helices at the N-terminus and others showing insertion sites between 
β5 and α7; and β6 and β7(Martin & McMillan, 2002).   
Here, we report the crystal structure of the AdoMet-dependent methyltransferase, 
BT_2972, from B. thetaiotaomicron VPI-5482 strain which shows various structural 
features: 1) there is no separate substrate binding domain; 2) there are no additional 
secondary structure at the C-terminus; 3) there are two small α helices (α1 and α2) at 
the N-terminus; and 4) there are helices between β5 and α7 (α6) and between β6 and 
β7 (α8 and α9), respectively (Figure 3.2A). Furthermore, E. coli Bl21 (DE3) 
harbouring the BT_2972 gene was tested for different antibiotic resistance 
(kanamycin, tetracyclins, erythromycin and chloroamphenicol). Each of these 
antibiotics retained their activity, suggesting that BT_2972 might not have a 
macromolecule substrate for methylation that confers antibiotic resistance.  Based on 
these structural features, sequence analysis and resistance tests; we suggest that 
BT_2972 is a small molecule methyltransferase of the ubiquinone/menaquinone 
biosynthesis pathway.  
The ubiquinone pathway involves three methylation steps while menaquinone 
pathway has one, with chorismate as the common intermediate for both pathways 
(Meganathan, 2001). The three steps of ubiquinone pathway are catalyzed by two 
methyltransferases encoded by the UbiG and UbiE genes. The UbiE-encoded 
methyltransferase is common amongst both pathways and is highly conserved 
amongst the bacteria. In the case of B. thetaiotaomicron   VPI-5482, this 
methyltransferase is annotated as BT_4216 (Xu et al., 2003). In contrast, the 
sequences for UbiG-encoded methyltransferases (ubiquinone biosynthesis SAM-
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dependent O-methyltransferase) are highly variable amongst the bacteria. This leads 
us to speculate that BT_2972 is a methyltransferase of the ubiquinone biosynthesis 
pathway and may represent the UbiG-encoded methyltransferase in B. 
thetaiotaomicron   VPI-5482 that catalyzes the two O-methyltransformation reactions 
in the ubiquinone biosynthetic pathway in bacteria. 
A key observation from our crystal structure in BT_2972 is the 
conformational change in the active site region upon cofactor binding which shows 
the opening and closing of the gate access to the active site. Conformational changes 
near the  AdoMet-binding site have been observed in other methyltransferases, such 
as in rat catechol-O-methyltransferase (Tsuji et al., 2009),  L-isoaspartyl (D-aspartyl) 
methyltransferases (Griffith et al., 2001), Betaine homocysteine S-methyltransferase 
(Gonzalez et al., 2004). In the case of rat catechol-O-methyltransferasee (PDB code 
1VID and 2ZLB), the conformational change occurs in the backbone atoms of the 
loop Lys36-Val42 (~12.0Å) upon AdoMet binding close to the carboxylpropyl 
moiety of AdoMet. However, this loop does not occupy the AdoMet binding site, and 
only upon cofactor binding the backbone of this loop move towards the caroboxyl 
moiety of AdoMet.  Further, the side chains that occupied the AdoMet binding site in 
the apo structure (His142 and Trp143) moved away (Figure 3.6A) to accommodate 
the incoming ligand (Tsuji et al., 2009).  In the case of L-isoaspartyl (D-aspartyl) 
methyltransferases (PDB code 1JG1 and 1JG4) (Griffith et al., 2001), only the side 
chains of Tyr192 and His193 flip outward between the AdoMet and AdoHcy 
complexes. In AdoMet-bound structure, these side chains project toward the cofactor; 
but in AdoHcy complex, these side chains flip outward (Figure 3.6B).  For the betaine 
homocysteine S-methyltransferase (Gonzalez et al., 2004), the backbone and the side 
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chain atoms of Phe76 and Tyr77 move upon substrate binding in comparison with its 
apo structure without interacting with the substrate (Figure 3.6C).  
Unlike with these previous examples, the conformational change in BT_2792 
is important for the ligand binding. The observed conformational change in the loop 
(Glu121-Ile127) in the active site is near to the ribose and adenosyl base binding 
region of the ligands, and is accomplished by the movement of the backbone atoms 
up to 9Å along with the side chain movement up to 12Å. Thus, to our knowledge, the 
conformational change observed in BT_2972 is unique.  
In summary, we report the crystal structures of an AdoMet-dependent 
methyltransferase BT_2972 from an antibiotic resistant bacterium B. 
Thetaiotaomicron VPI-5482. BT_2972 is the first representative structure of an 
AdoMet-dependent methyltransferase of the ubiquinone biosynthesis pathway from 
Bacteroides genera. The comparison between the structures of the apo and 
AdoMet/AdoHcy complexes revealed the closed and open forms of the active site that 
may regulate cofactor movement and substrate interactions.  The isothermal titration 
calorimetric studies showed a different binding affinity for BT_2972 with AdoHcy 
and AdoMet. The structural and sequence analyses, combined with literature, suggest 
that BT_2972 is a small molecule methyltransferase that may catalyze two O-


























Figure 3.6: A) Comparison of apo (red) and AdoMet bound (blue) rat catechol-O-
methyltransferase (PDB code- 2ZLB and 1VIB, respectively). A large conformational 
change takes place in the loop Lys36-Val42 upon AdoMet binding that moves this 
loop towards the AdoMet (left panel). Also in the same structure a side chain 
movement was observed for the residue His 142 and Trp 143 (right panel). AdoMet is 
shown as stick representation in green B) In L-isoaspartyl (D-aspartyl) 
methyltransferases (PDB code 1JG1 and 1JG4), the side chain was flipped out in the 
residues Tyr192 and His193 between AdoMet (red) and AdoHcy (blue) complexes. 
C) Figure shows the conformational change in betaine homocysteine S-
methyltransferase (PDB code: 1UMY and 1LT8) upon substrate binding. The 
backbone and the side chain atoms of Phe76 and Tyr77 were moved in the substrate 
(CBH) complex in comparison with its apo structure. Apo protein is shown in red and 










Structural Characterization of BVU_3255, 
a Methyltransferase from Human Intestine 















4.1 Introduction  
The adult human intestine contains trillions of bacteria dominated by the 
genus Bacteroides(McCarthy et al., 1988), a group of gram-negative, rod-shaped, 
anaerobic bacteria that do not form spores and are non-motile (Bakir et al., 2006). 
Typically, Bacteroides are symbionts, but they can also be opportunistic pathogens. 
In the human intestine, specific Bacteroides are responsible for digesting different 
polysaccharides, such as amylose, amylopectin and pullulan, which support rapid and 
high growth yields; however, Bacteroides are unable to degrade plant cell wall 
polysaccharides. One of the most common species in the human intestine, 
Bacteroides vulgatus, accounts for approximately 12% of this bacterial population 
(Bakir et al., 2006).   
Previously, the complete genome sequence of the B. vulgatus ATCC 8482 was 
reported (Xu et al., 2007). BVU_3255 is a 29.8 kDa protein (accession no 
YP_001300506.1) of this proteome and is a putative methyltransferase, with an S-
adenosyl-L-methionine (SAM)-binding domain. Methyltransferases (EC 2.1.1) 
catalyze the transfer of a methyl group from a donor molecule (SAM) to an acceptor 
molecule (substrate), such as DNA, RNA, proteins and other small molecules and 
leaving the product SAH (S-Adenosyl-L-Homocysteine). Methyltransferases regulate 
important cellular and metabolic functions, including antibiotic resistance (Miller et 
al., 2003, Husain et al., 2010); yet, to date, there has been no report of any 
methyltransferase structure from B. vulgatus.  
In this chapter we report the crystal structure of apo BVU_3255 and its complex with 
SAM and SAH, along with the isothermal titration calorimetric studies. These studies 
revealed that BVU_3255 adopts a classical SAM-dependent methyltransferase 
architecture with a characteristic α/β fold and thus belongs to the class I Rossmann-
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Fold Methyltransferases (RFM) (Bujnicki, 1999).  In addition, the structural and 
sequence analysis provide evidence that BVU_3255 is a small molecule 
methyltransferase of ubiquinone biosynthesis pathway. 
 
4.2 Materials and Methods 
4.2.1 Cloning, expression and protein purification  
BVU_3255 was cloned into expression vector pGS21a (GeneScript, USA) and  was 
purified to homogeneity using a two-step procedure involving Ni2+-NTA affinity and 
gel filtration chromatography in a buffer consisting of Tris-HCl (pH 8.0) and 200 mM 
NaCl.  The homogeneity of BVU_3255 was verified by dynamic light scattering 
(DLS) experiments.  Please refer chapter 2 for detailed cloning, expression and 
purification.  
 
4.2.2 Crystallization and structure determination  
A detailed crystal optimization and data collection strategy are described in chapter 
two of this thesis. Initial phases were obtained by molecular replacement method 
using the program Molrep-auto MR (Vagin & Teplyakov, 2010) in CCP4 suite. 
Where required, manual model building was done using COOT (Emsley & Cowtan, 
2004) and alternatively refined by CNS (Brunger et al., 1998).  The final models  
have good stereochemistry, as analysed by PROCHECK (Laskowski et al., 1993). All 
structure-related figures reported here were generated using PyMol (DeLano & Lam, 





4.2.3 Isothermal titration calorimetry  
The ITC binding studies of SAM and SAH with apo BVU_3255 were performed 
using a VP-ITC calorimeter (Microcal, LLC) at room temperature with 0.2 ml of 
SAM/SAH in the injector cell and 1.8 ml of BVU_3255 in the sample cell. The 
protein and ligands were kept in a buffer consisting of 20 mM Tris-HCl (pH 8.0) and 
200 mM NaCl. 10 µl injection volumes were used for all experiments. Two 
consecutive injections were separated by 5 min to reset the baseline. The control 
experiment, consisting of titration of SAM/SAH against buffer, was performed and 
subtracted from each experiment to adjust for the heat of dilution of ligands. ITC data 
were analyzed with a single-site fitting model, using Origin 7.0 software (OriginLab 
Corp.).  
 
4.2.4 PDB Code 
The coordinates and structure factors of apo, SAM and SAH complex of BVU_3255 
were deposited in the RCBS (Bernstein et al., 1977) database with the access code 
3T7R, 3T7S, and 3T7T respectively. 
 
4.3. Results and discussion 
 
4.3.1 Overall structure 
 
The crystal structure of the apo BVU_3255, as well as the co-crystal structures of 
BVU_3255 in complex with SAM and SAH, were solved by molecular replacement 
method and refined to a resolution 2.9, 2.2 and 2.5 Å, respectively (Figure 4.1, Table 
4.1). There were two molecules in the asymmetric unit of the apo BVU_3255 and 
four molecules in the SAM/SAH complexes. However, the gel filtration and dynamic 
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light scattering experiments showed that BVU_3255 exists as a monomer in solution. 
The BVU_3255 construct had a total of 262 amino acids and an N-terminal (His)6-
tag. This tag and the first 12 residues at the N-terminus were not well-defined in the 
electron density map and were not included in the model.  The BVU_3255 molecule  
exists as a single-domain globular protein, with both the cofactor and substrate 
binding site in the same domain, a common feature observed for the small molecules’ 
methyltransferases (Martin & McMillan, 2002).  The active site of BVU_3255 
comprised seven-stranded β sheets (β3↓-β2↓-β1↓-β4↓-β5↓-β7↑-β6↓), flanked by three 
α-helices at both the N- (α2,α3,α4) and C-termini (α5, α6, α7) (Figure 4.1), 
characteristic of a typical SAM-dependent class I RFM (Bujnicki, 1999). The helices 














Figure 4.1: A) The crystal structure of BVU_3255-SAM complex. The N- and C-
termini and the secondary structural elements are labelled (α helices in violet; β 
strands in yellow; loops in green). Stereo view of SAM (B) and SAH (C) complexes 
at the active site region, with SAM in cyan, SAH in orange and interacting residues 
from BVU_3255 in yellow. Simulated annealed Fo-Fc omit maps (ligands and 3.5 Å 
of its surroundings were omitted) were contoured at a level of 3σ. For clarity, only 
selected side chains are shown. 
 
 
Several structural features separate small molecule and macromolecular 
methyltransferases. By examining the structures of known methyltransferases, the 
SAM-binding region is conserved but the substrate binding site is highly variable 
depending upon the methylation substrate (Martin & McMillan, 2002). In the case of 
macromolecular methyltransferases, where the substrate is relatively large in size, the 
substrate binding site has been shown to be located in a different portable domain, 
with an additional secondary structural element at the C-terminus.  In contrast, in 
C 
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small molecule methyltransferases, the substrate binding site is generally located in 
the same domain adjacent to the cofactor binding site, and these methyltransferases 
lack any additional C-terminal secondary structures (Martin & McMillan, 2002). 
Further, the majority of small molecules methyltransferases have two additional 
helices at the N-terminal region, and have insertions in the C-terminal part of the core 
SAM-binding domain (between β5 and α7; β6 and β7). Overall, the current structure 
points to BVU_3255 as a small molecule methyltransferase. 
 
4.3.2 SAM and SAH binding site   
Both SAM and SAH were shown to bind within the active site, with their adenosyl 
base moiety facing outside and their carboxypropyl moiety buried inside. Both 
ligands made equal interactions with BVU_3255. Residues, such as Arg26, Gln27, 
Gly55, Gly57, Gln61, Glu122, and Gly123 were involved in hydrogen bonding 
contacts (< 3.2 Å) with the carboxypropyl moiety of the ligands, while the ribose ring 
contacted with residues Asp77, Phe78, Phe79 and Asn127 (Figure 4.1B and 4.1C). 
The Asp77 position is conserved in all known SAM-dependent methyltransferases, 
with either an Asp or a Glu residue (Lim et al., 2001). Gly104, Ser105, and Met106 
made interactions with the adenosyl moiety of the ligands. The superposition of apo 
BVU_3255 onto both SAM and SAH complexes yielded an RMSD less than 0.6 Å 






























aReflections with I>σ was used in the refinement. 
bRwork = |Fobs – Fcalc|/|Fobs| where Fcalc and Fobs are the calculated and observed 
structure factor amplitudes, respectively. 
cRfree = as for Rwork, but for 5% of the total reflections chosen at random and omitted 
from refinement. 
dIndividual B-factor refinements were calculated. 




4.3.3 Isothermal titration calorimetry  
The interactions between BVU_3255 and SAM/SAH were studied by ITC 
experiments (Figure 4.2). Consistent with the crystal structure, the ITC experiments 
showed a single-site binding model for both ligands. The binding parameters for SAH 
were: Ka=2.955×104 M−1 (± 0.2404 × 104), ΔH=−5.74 kcal/mol (±0.219), and 
N=1.23.±0.20; and for SAM were: Ka=4.45×104 M−1 (±0.63×104), ΔH=−5.533 
kcal/mol (±0.359), and N=0.85±0.01 (where Ka is the association constant, ΔH is the 
change in enthalpy, and N is the number of binding sites). These ITC experiments 
showed that both SAM and SAH bind to BVU_3255 with a similar affinity, 
consistent with the observation from the complex structures that both ligands had 
similar interactions with BVU_3255. 
 Native SAM SAH 
Refinement and quality a    
Resolution range (Å) 30.0 – 2.9 30.0 - 2.2 30.0 - 2.5 






Rfreec (no. of reflections) 0.28(746) 0.26(2176) 0.27(2163) 




RMSD bond angles(o)  1.226 
 
1.244 1.305 
Average B-factorsed (Å2)    
     Main chain 41.7 40.5 31.3 
     Side chain 42.7 42.5 32.4 
     Ligand 51.8 33.7 22.4 
Ramachandran plot    
Most favored regions (%) 91.0 90.1 92.1 
Additional allowed 
regions (% 
8.5 9.6 7.9 
Generously allowed 
regions (%) 
0.5 0.4 0.0 






















Figure 4.2: ITC profile of BVU_3255 titrated against (A) SAM and (B) SAH. The 
upper panels show the raw ITC data for injection of ligands into the sample cell 
containing the native protein. The peaks were normalized to the ligand:protein molar 
ratio and were integrated as shown in the bottom panels. Solid dots indicate the 
experimental data, and their best fit was obtained from a nonlinear least squares 
method, using a one-site binding model depicted by a continuous line. 
 
4.3.4 Sequence and structural homology 
Class I methyltransferase share low overall sequence homology. Depending on the 
methylation target, their substrate binding site varies. However they share structure 
and sequence similarity at the active site. Previous bioinformatics studies on Class I 
methyltransferases have shown that the structure of the AdoMet binding site is 
conserved in the primary sequences of four short signature motifs designated Motifs 
I, Post I, II, and III.  A PSI-BLAST search revealed that BVU_3255 shared sequence 
A B
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homology with several SAM-dependent class I RFMs. It exhibited a maximum 
identity of 62% with a methyltransferase of known function involved in ubiquinone 
biosynthesis from B. Xylanisolvens. This was followed by 48% identity with a similar 
ubiquinone methyltransferase from Gordonibacter pamelaeae (Fig 4.3). BT_2972 
and BVU_3255 share ~59% sequence identity. This sequence analysis indicated that 
BVU_3255 is a small molecule methyltransferase and might be involved in 
methylating the intermediates in the ubiquinone/menaquinone biosynthesis pathway. 
In the ubiquinone/menaquinone biosynthesis pathway there are three methylation 
reactions catalyzed by UbiG and UbiE methyltransferases (Meganathan, 2001). 
Previously Xu et al. annotated BVU_2542 as the UbiE in B. vulgatus ATCC 8482 (Xu 
et al., 2007).  BVU_2542 is common for ubiquinone and menaquinone biosynthesis 
pathways and catalyzes a methylation reaction in both the pathways. Thus, 
BVU_3255 may be the UbiG SAM-dependent O-methyltransferase of the ubiquinone 
biosynthesis pathway; UbiG enzymes act at two intermediates in the ubiquinone 
biosynthetic pathway.  
A search for structurally similar proteins in DALI server (Holm & Sander, 1995) 
resulted in similarity with several proteins belonging to class 1 RFMs. The highest 





Figure 4.3: Structure-based sequence alignment of BVU_3255 with different mycolic 
acid methyltransferases from M. tuberculosis. Sequence similarities are highlighted in 
red, whereas sequence identities are shown as white letters on a red background. The 
secondary structural elements are shown on the top. Structural alignment was 
performed in DALI server while sequence alignment was carried out using  ClustalW 
(Chenna et al., 2003) with default parameters. The diagram shown here was 




Crystal structures of three members of mycolic acid cyclopropane synthases have 
been reported, namely CmaA1, CmaA2, and PcaA (Huang et al., 2002). All three 
family members are highly similar to each other and to BVU_3255 (DALI score 22.1, 
RMSD 3.0 Å for Cα 235 residue pdb code 1KPG for CmaA1). Mycolic acid 
cyclopropane synthases are also SAM-dependent proteins, with a similar α/β 
Rossmann Fold, and are involved in the site-specific methylation of mycolic acid, a 
major component of the Mycobacterium cell wall (Huang et al., 2002). All of these 
structures are similar, and the structure-based sequence alignment shows several 
conserved key residues in their active site region (Figure 4.3).  
 
4.3.5 Inferred substrate binding site  
A one-to-one structural comparison between BVU_3255-SAH/SAM and CmaA1-
SAH-CTAB (substrate, Cetyltrimethylammonium Bromide) (PDB: 1KPG) showed 
the existence of a highly conserved active site and substrate-binding site. The 
orientation of the cofactor for both proteins is the same (Figure 4.4A).  On closer 
examination of the active site, we observed that the carboxypropyl portions of SAH 
from both proteins are in the same plane, but the ribose and adenosyl moieties are not. 
The N6 atoms of the adenosyl bases are approximately 3.5 Å apart. Nonetheless, the 
cofactors in both proteins occupy the same region in the active site. In addition, an 
extra electron density map was observed in the apo BVU_3255 in the same place 
where the CTAB (substrate) binds CmaA1. This electron density lies adjacent to the 
transferable methyl group of SAM (Figure 4.4B) and is surrounded by bulky amino 
acids that make the environment highly hydrophobic for interaction with the 
hydrophobic ligand. These observations s suggests that this additional electron 






Figure 4.4: A) Stereo view of superposition of Cα trace of BVU_3255-SAH (yellow) 
and mycolic acid cyclopropane synthase CmaA1-CTAB-SAH complex (green) from 
M. tuberculosis (PDB 1KPG). SAH of BVU_3255 is shown in orange and SAH of 
CmaA1 in light blue. The active site of the two proteins superimposed well, and SAH 
occupies the same region in the active site.  Carboxypropyl moieties of SAH from 
both the proteins are lying in same plane but ribose and adenosyl moieties are 
separated by 3.5Å.  The substrate CTAB of CmaA1 is shown in pink. B) Based on the 
superposition the substrate binding site on BVU_3255-SAH complex was inferred. A 
part of the proposed substrate (5 carbon atoms of the aliphatic chain attached to 
benzene ring) of BVU_3255 was modelled into the observed additional electron 
density at the region where CTAB is mapped onto BVU_3255. Simulated annealed 
Fo-Fc omit maps (ligand and 3.5 Å of its surroundings were omitted) were contoured 






Sequence analysis suggested that BVU_3255 is involved in the ubiquinone 
biosynthesis pathway and may function to methylate two intermediates of the 
pathway i.e. 2-polyprenyl-6-hydroxyphenol and 2-polyprenyl-3-methyl-5-hydroxy-6-
methoxy-1, 4-benzoquinone. The substrate CTAB (for CmaA1) and the proposed 
BVU_3255 substrates are similar, except BVU_3255 substrates have a benzene ring 
that contains the methylation site (Figure 4.4B). The observed electron density 
allowed us to build a benzene ring and 5 carbon atoms of the aliphatic chain attached 
to benzene ring of the substrate. However, no well-defined density was observed for 
the rest of the alkyl side chain. Overall, our analysis and observations support the 
view that substrates for BVU_3255 are similar to mycolic acid, with a long aliphatic 
chain attached to the benzene ring, although further experimental verification is 
warranted. 
In summary, in this chapter we report the first representative crystal structures of a 
SAM-dependent methyltransferase, BVU_3255, from an antibiotic-resistant 
bacterium, B. vulgatus.  The isothermal titration calorimetric studies showed that both 
SAM and SAH bind to BVU_3255 with a similar affinity.  The structural and 
sequence analysis indicated that BVU_3255 is a small molecule methyltransferase 
that may be involved in catalyzing (methylates) the two O-methylation reaction steps 


































In this study we have met our objectives of studying the two O-methyltransferase 
BT_2972 and BVU_3255. These studies lead to the first complete structural 
characterization of representative methyltransferase structures from the respective 
Bacteroides bacteria.  Structure of BT_2972 adopts a typical class I Rossmann-like 
AdoMet-binding fold at the catalytic site that is common to all class I AdoMet-
dependent methyltransferases, comprising a seven-stranded β-sheet 
(β3↓β2↓β1↓β4↓β5↓β7↑β6↓) flanked by three α helices on both sides. The apo and 
ligand bound BT_2972 structure are similar other than the active sites. The 
comparison between the structures of apo and AdoMet/AdoHcy revealed the closed 
and open forms of the active site which could potentially regulate the movement of 
the cofactors and the interactions with the substrate.  The isothermal titration 
calorimetric studies showed that BT_2972 binding affinity with AdoHcy and AdoMet 
are slightly different.  
 Similarly, the all BVU_3255 crystal structures also adopt class I Rossmann fold at 
the active site. The three structures are very similar and no major conformational 
change was observed between apo and ligand bound structures. An additional 
electron density was observed in the native structure at the active site, next to the 
AdoMet binding site.  This density was modelled with proposed substrate. The 
isothermal titration calorimetric studies showed that both AdoMet and AdoHcy bind 
with BVU_3255 in a similar affinity.   
The structural and sequence analysis suggested that both proteins BT_2972 and 
BVU_3255 are a small molecule methyltransferase and probably catalyzes 
(methylates) two O-methylation reaction step intermediates in the ubiquinone 
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biosynthesis pathway. ITC study of ligand binding suggested that BT_2972 bind to 
the ligand (AdoMet/AdoHcy) with 10 fold higher affinity than BVU_3255.  
In both the structures, the substrate binding site is located within the same domain 
where AdoMet/AdoHcy binds. This is the characteristic feature of small molecule 
methyltransferase. Structure and sequence similarity allowed us to predict the target 
substrate for the two methyltransferases. Structural comparison suggests that these 
two methyltransferases are very similar to the mycolic acid methyltransferase from 
M. tuberculosis; the AdoMet/AdoHcy binding sites are conserved and the substrate 
binding site is next to AdoMet/AdoHcy in order to facilitate the methyl transfer.  
 
5.2 Future Directions 
Despite the fact that we have presented the crystal structural and biophysical 
characterization of two O-methyltransferases from ubiquinone pathway, some of 
experiments need to be performed to validate the proposed substrate.  The predicted 
substrate for these two methyltransferases, i.e.  the intermediates of the ubiquinone 
biosynthesis pathway -1) 2-polyprenyl-6-hydroxyphenol and 2) 2-polyprenyl-3-
methyl-5-hydroxy-6-methoxy-1, 4-benzoquinone  needs to be verified experimentally 
both in vitro and in vivo study.   In vitro, this can be performed by incubating the 
substrate with enzymes and AdoMet followed monitoring the profile using Thin 
Layer chromatography (TLC). For in vivo based study, it might be verified by 
knocking out the genes and then monitoring quantity of the intermediates of 
ubiquinone pathway.  
Our future work will also focus on co-crystallize the ternary complex of enzymes-








Interactions of the Intrinsically Disordered 
Neuron Specific Substrate Proteins 
Neuromodulin (Nm) and Neurogranin (Ng) 
with Calmodulin (CaM) Revealed by 











6.1.1 Neuron  
The nervous system is an organ system made of a network of specialized cells known 
as neurons (Figure 6.1).  The nervous system controls the actions and behaviour of 
the animals by transmitting the signals between different parts of the body. It consists 
of two parts called the central nervous system and the peripheral nervous system. 
The central nervous system (CNS) consists of the brain, the spinal cord, (in some 
cases) retina and the cranial nerves.  CNS integrates the information that it receives 
from, and coordinates the activity of, all parts of the bodies of animals. The peripheral 
nervous system (PNS) consists of the nerves and ganglia and together with CNS, it 









The neuron transmits information in the form of chemical and electrical signal. 
Neurons have three distinct structures known as the dendrites, the cell body and the 
axon. The axon and dendrites are responsible for transmitting and receiving the 
information (Figure 6.1 and 6.2). The connections between two neurons are known as 
synapses. Neurons release chemicals known as neurotransmitters into these synapses 
to communicate with other neurons (Figure 6.2). Unlike other body cells, neurons do 
not reproduce shortly after birth. Other body cells keep on reproducing new cells 
throughout the life. But neurons stop reproducing new neuron after birth.  Because of 
this, some parts of the brain have more neurons at birth than later in life because 
neurons die but are not replaced. There are several types of neurons responsible for 
different tasks in the human body. Sensory neurons are involved in carrying 
information from the sensory receptor cells throughout the body to the brain. Motor 
neurons are responsible for transmitting information from the brain to the muscles of 
the body. Inter neurons are involved in communicating information between different 
neurons in the body. 
6.1.2 Action Potentials 
Neurons communicate by transmitting information within the neuron and from one 
neuron to the next. The dendrites of neurons receive information from sensory 
receptors or from other neurons. This information is then passed down to the cell 
body and on to the axon. Information in the neuron travels in the form of electrical 
signals and chemical messengers. The information (after arriving at the axon) travels 
down the length of the axon in the form of an electrical signal known as an action 




Figure 6.2: The synapse is the connection between nerve cells (neurons) in animals 
including humans. The synapse joins the axons in one neuron to the dendrites in 
another. (Adapted from http://www.mult-sclerosis.org/synapse.html) 
 
 
6.1.3 Communication between Synapses 
Once an action potential has reached the end of an axon, the information from axon 
transmits across the synaptic gap to the dendrites of the adjoining neuron by one of 
the two processes. In some cases, the action potential can almost instantaneously 
bridge the gap between the neurons and continue along its path. In other cases, 
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neurotransmitters are released that carry the information from one neuron to the next. 
Neurotransmitters are chemical messengers that are released from the axon terminals, 
travels cross the synaptic gap and reach the receptor sites of other neurons.  These 
neurotransmitters attach to the receptor site and are reabsorbed by the neuron to be 
reused. Some examples of neurotransmitter are acetylcholine, endorphins, and 
dopamine. 
 
6.1.4 Long term potentiation (LTP) 
LTP is a long-lasting enhancement in signal transmission between two neurons that 
results from stimulating them synchronously. It is one of the several phenomena 
underlying synaptic plasticity and is considered as one of the major cellular 
mechanisms that underlie learning and memory. LTP is thus associated with long-
term memory formation. LTP and long-term memory are triggered rapidly, both 
depends upon the synthesis of new proteins, each has properties of associativity, and 
each can last for many months (Malenka & Bear, 2004).  LTP enhances synaptic 
transmission by improving the ability of two neurons (presynaptic and postsynaptic) 
to communicate with one another across a synapse.   
 
6.1.5 Long term depression (LTD) 
LTD is a reduction in the efficacy of neuronal synapses lasting hours or longer. LTD 
has been found to occur in different types of neurons at the synapses. LTD is the 
opposing process to LTP. LTD mainly takes place because of decrease in 
postsynaptic receptor density or a decrease in presynaptic neurotransmitter release. It 
is important for motor learning, clearing of old memory traces. LTD is also found to 
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selectively weaken specific synapses in order to make constructive use of synaptic 
strengthening caused by LTP.  
In this part of the thesis we focus on two neuron specific proteins Neuromodulin(Nm) 
and neurogranin (Ng) and their interacting partner in neuron Calmodulin (CaM).  
 
6.2 Growth Associated Protein-43 (GAP-43, Nm) 
The neuron specific substrate protein Neuromodulin (23.6kda, aka Nm, B50, GAP-
43, F1, or P-57) is acid stable and hydrophilic in nature. It was discovered and 
isolated by virtue of its novel CaM binding properties (Benowitz & Routtenberg, 
1987, Andreasen et al., 1981). Neuromodulin (here after referred as Nm) was purified 
by application of detergent-solubilized bovine brain membranes to CaM-sepaharose 
in the presence of excess Ca2+ chelator and then eluted from CaM-sepharose with a 
Ca2+ containing buffer. Nm binds CaM through a short conserved IQ motif 
[I,L,V]QxxxR[G,x]xxx[R,K]  under a low Ca2+ micro-environment while reduces that 
affinity when Ca2+ level increases. IQ motif contains mainly basic and hydrophobic 
residues, in particular lysine and arginine (Slemmon et al., 1996), with a high 
propensity to form an amphipathic α helix and is thought to be the main structural and 
functional domain. A proposed biochemical function for Nm is to sequester CaM in 
the vicinity of CaM – activated enzymes under low Ca2+ condition. Elevations of 
intracellular free Ca2+ would promote dissociation of CaM from Nm, allowing rapid 
CaM activation of enzyme activity. The Nm- CaM interaction is also regulated by 
protein kinase C (PKC) mediated phosphorylation. PKC phosphorylates Ser41 
residue within IQ motif of Nm and reduces its affinity towards CaM (Alexander et 
al., 1987). Phosphorylation of Ser41 residue of Nm by PKC regulates neurite 
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formation, regeneration, and synaptic plasticity (Benowitz & Routtenberg, 1997a) 




Figure 6.3: Schematic model of Nm membrane interaction and its regulation by PKC 












Figure 6.4: Role of CaM and Nm at presynaptic loci in LTP. This figure is adapted 
from(Xia & Storm, 2005). 
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The amino acid composition of the Nm is very unusual. The protein contains a single 
phenylalanine with no other aromatic residue, while alanine, glutamic acid, lysine and 
proline are abundant. Nm can attach to the membrane via a 
dual palmitoylation sequence on Cys3 and Cys4. It is also found as non bound form 
in cytoplasm and centrosome.  This sequence (Cys3 and Cys4) targets Nm to lipid 
rafts (Figure 6.3).  Centrosome and mitotic spindles are found to be mislocalized in 
the neuron cells that unable to express Nm during cell differentiation. Nm also plays a 
critical role in the development of the central nervous systems (Strittmatter et al., 
1995). Nm is an intrinsic determinant of structural change at the synapse.  Nm binds 
to actin (He et al., 1997) and spectrin (Riederer & Routtenberg, 1999), and by such 
protein–protein interactions affects morphological change at the synapse. This 
synaptic plasticity has been implicated in memory storage processes (Cammarota et 
al., 1997).   
 
In the neuron cell, Nm is localized at the cytoplasmic face of the plasma membrane of 
axonal and presynaptic terminals of synapses. During the neural development, Nm 
accumulates in axonal growth cones and helps them to navigate exactly to their 
appropriate targets (Benowitz & Routtenberg, 1997b, Shen et al., 2002).  Nm is also 
involved in neurite extension and neuronal plasticity, neuroregeneration, regulation of 
neurotransmitter release at presynaptic terminal and long term potentiation (LTP) 
(Denny, 2006, Mosevitsky et al., 2001, Mosevitsky, 2005, Doster et al., 1991, 
Fitzgerald et al., 1991, Gianotti et al., 1992) Figure 6.4). Nm is not reported to found 
in tissue other than brain, retina and spinal cord (Cimler et al., 1985). In the nervous 
system, Nm overexpression is accompanied by enhanced learning and regenerative 
capabilities (Routtenberg et al., 2000). Recent study suggests that the protein kinase 
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C phosphorylation site on Nm differentially regulates performance of three different 
memory-associated tasks (Holahan & Routtenberg, 2008).  
 
Genetically over expression of Nm is able to enhance the learning and LTP in 
transgenic mice. A substitution mutation in Nm at Ser41 (which is the 
phosphorylation by protein kinase C) to Ala has been shown to block 
phosphorylation. The over expression of mutated Nm does not show any 
enhancement in learning. These findings suggest that a growth-related gene (GAP-
43/Nm) regulates learning and memory and also suggest that the Nm phosphorylation 
site is the main target for enhancing cognitive ability. Since learning increases Nm 
phosphorylation, one might expect that a transgenic mouse that over expresses 
phosphorylable Nm would demonstrate enhanced learning. A contradiction to this 
prediction is that such genetically enhanced learning would not occur if the PKC site 
of the over expressed Nm were mutated to prevent its phosphorylation. Figure 6.5 
explains the proposed mechanisms of enhanced learning in transgenic animals over 
expressing Nm. At the presynaptic terminal PKC is activated by an NMDA-
dependent postsynaptic retrograde signal. Phosphorylated endogenous Nm (black 
circle) interacts only with calcium-sensor proteins of the exocytotic protein machine 






Figure 6.5: A Proposed mechanistic model to elucidate the enhanced LTP in 




But this is not sufficient to induce LTP. So, PKC also phosphorylates both 
endogenous and transgenic G-Phos (red circle) and now the terminal is “primed” to 
release more transmitters upon subsequent depolarization of the presynaptic terminal. 
Because the G-Perm variant of Nm (blue square) can bind to activated EPM without 
PKC phosphorylation, this mutated form of Nm does not require the influence of 
NMDA receptor activation.   
 
Nm also has been shown to interact with a number of different molecules, like 
PKC, PIP2, actin, CaM, spectrin, palmitate, synaptophysin, amyloid and tau protein. 
Its important role in memory and information storage is executed through its cell 
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biological mechanisms of phosphorylation, palmitoylation, protein-protein interaction 
and structural remodeling via actin polymerization.  
 
6.3 Neurogranin (Ng) 
Another neuron specific PKC substrate protein called neurogranin (7.6 kDa, Ng) is 
also acid stable but expressed at postsynaptic cytosol loci in several telencephalic 
areas such as cerebral cortex, hippocampus, amygdale, striatum and olfactory bulb in 
mammalians (Neuner-Jehle et al., 1996). Its expression controlled by thyroid 
hormone (Bernal et al., 1992), retinoic acid, and vitamin A(Husson et al., 2003), is 
developmentally regulated, showing a relatively low expression in the embryonic and 
neonatal stages and a dramatic increase from 2 to 3 weeks of age (Alvarez-Bolado et 
al., 1996). In neurons, it is found in higher concentration at dendritic spines where it 
participates in synaptic signalling events.  
 
Ng is the member of calpactin protein family which includes other protein such as 
Nm, peptide protein 19 (PEP-19), Igloo and sperm protein 17 (SP-17) (Ran et al., 
2003). Similar to other proteins of this family Ng binds to CaM in low Ca2+ 
environment and releases CaM under high Ca2+ condition. Its CaM-binding affinity is 
modulated by phosphorylation (Huang et al., 1993), oxidation (Ran et al., 2003) or S-
glutathiolation(Li et al., 2001). Ng is involved in the regulation of CaM and CaM – 
activated protein enzymes, such as nitric oxide synthase, Ca2+/CaM-dependent 
protein kinase II and CaM-dependent adenylate cyclise (Huang et al., 2004). Since 
most CaM-activated proteins are involved in long term potentiation (LTP) and long 
term depression (LTD), the timing pattern of Ng gene expression and protein 
synthesis appears to coincide with CaM-related synaptogenesis and development. The 
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Ng protein may play an important role in the neuroplasticity mechanism of learning 
and memory (Huang et al., 2004). Ng features an IQ motif that mediates its 
interaction with CaM and also with phosphatidic acid (PA) and IQ motif becomes 
phosphorylated by protein kinase C (PKC) at Ser36. Ser36-phosphorylated Ng is 
unable to bind either CaM or PA (Diez-Guerra, 2010). In addition, changes in Ng 
expression levels may be associated with some cerebral pathophysiologic conditions, 
such as hypothyroidism, sleep deprivation, and brain aging(Li et al., 2003). 
Transgenic knock-out mice lacking expression of Ng shows deficiency in learning 
and memory, activation of Ca2+/CaM-dependent protein kinase II, attenuation of PKC 
and cAMP-dependent protein kinase signal transduction (Miyakawa et al., 2001, Wu 
et al., 2002) 
 
Synaptic plasticity in CA1 hippocampal neurons depends on Ca2+ elevation and the 
resulting activation of CaM-dependent enzymes. Induction of long-term depression 
(LTD) depends on calcineurin, whereas long-term potentiation (LTP) depends on 
Ca2+/ CaM-dependent protein kinase II (CaMKII). The concentration of CaM in 
neurons is considerably less than the total concentration of the apo CaM-binding 
proteins Ng and NM, resulting in a low level of free CaM in the resting state. Ng is 





















Figure 6.6: Role of Ng and CaM at postsynaptic loci in LTP and LDP. Figure 
adapted from (Xia & Storm, 2005).  
 
Ng also acts as a pro-apoptotic factor and regulates the cell death by apoptosis. It has 
been shown that the overexpression of Ng in a T-cell line (dependent on IL2) 
can induce apoptosis even in the presence of IL2. This apoptosis inducement by Ng 
coincides with a rise in intracellular Ca2+ levels. The effect can be prevented by 
treatment with a chelator of Ca2+. Mutants of Ng that are unable to bind CaM fail to 




 The role of Ng in synaptic plasticity has been elucidated with emphasis on the 
interaction of CaM with Ng, calcineurin, and CaMKII (Figure 6.6). The Ca2+ 
transients that occur during LTD or LTP induction affect CaM which results in 
activation of calcineurin and CaMKII affects AMPA receptor-mediated transmission. 
Knocking out of Ng protein strongly diminishes the LTP and slightly enhances LTD.  
Thus CaM should be stored in spines in the form of rapidly dissociating CaM-Ng 
complexes to induce LTP (Zhabotinsky et al., 2006).  
 
Ng enhances synaptic strength through its interaction with CaM. Learning-correlated 
plasticity at CA1 hippocampal excitatory synapses is dependent on neuronal activity 
and (NMDAR) activation (Figure 6.7). Ng enhances postsynaptic sensitivity and 
increases synaptic strength in an activity- and NMDA receptor-dependent manner. In 
addition, Ng-mediated potentiation of synaptic transmission mimics and occludes 
LTP. Expression of Ng mutants that lack the ability to bind, or dissociate from, CaM 
fails to potentiate synaptic transmission, strongly suggesting that regulated Ng–CaM 
binding is necessary for Ng-mediated potentiation. Thus, Ng–CaM interaction can 
provide a mechanistic link between induction and expression of postsynaptic 
















Figure 6.7: Schematic diagram illustrating Neurogranin involvement in postsynaptic 




Learning-related modifications of synaptic transmission at CA1 hippocampal 
excitatory synapses are activity- and NMDA receptor-dependent. As mentioned 
above a postsynaptic increase in Ca2+ is absolutely required for synaptic plasticity 
induction, the molecular mechanisms underlying the transduction of synaptic signals 
to postsynaptic changes are not clearly understood.  Zhong and Gerges have reported 
that the postsynaptic CaM-binding protein Ng enhances synaptic strength in an 
activity- and NMDAR-dependent manner (Zhong & Gerges, 2010).  
 
6.4 Calmodulin (CaM)  
CaM, a 148 residue protein (16.7 kDa) found in all eukaryotic cells, has been 
extensively studied as a primary Ca2+-binding protein. CaM is expressed in almost all 
cell types and assumes different subcellular locations like the cytoplasm, endoplasmic 
reticulum,  sarcoplasmic reticulum, within organelles, or associated with 
the plasma or organelle membranes (Fok et al., 2008). CaM is thought to mediate 
processes such as inflammation, metabolism, apoptosis, smooth 
muscle contraction, intracellular movement, short-term and long-term memory, nerve 
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growth and the immune response (Geiser et al., 1991). Post-translational 
modifications, such as phosphorylation, acetylation, methylation and proteolytic 
cleavage take place in CaM and affect the function of CaM (Murtaugh et al., 1983).  
CaM has four EF-hand motifs (two in each domain) that  are site for calcium binding 
and change conformation upon binding calcium ions (Yap et al., 1999). EF motifs 
provide suitable electronegative environment for Ca2+ ion coordination. EF-hand 
motif consists of two alpha helices that are connected by a 12-residue loop. In apo 
CaM (Ca2+ free), the alpha helices in the EF-hand motifs are positioned almost 
parallel to each other. This is referred as the closed conformation of CaM. When the 
intracellular calcium level rises to 10-5 M, four Ca2+ ions bind to CaM, one in each EF 
motif. Ca2+ induces a large conformational change in CaM molecule. In Ca2+-CaM, 
the alpha helices of the EF-hand motifs change their position relative to each other, 
forming an almost perpendicular conformation (Figure 6.8). This form is refereed as 
open conformation of CaM. The crystal structure of Ca2+-CaM exhibits a dumbbell 
shape (Babu et al., 1988, Babu et al., 1985). This conformational change exposes 
hydrophobic methyl groups from methionine residue in CaM that facilitates Ca2+-
CaM to increase its binding affinity for a number of Basic Amphiphilic Helices (BAA 
helices) on target proteins (Dash et al., 1997).  It has been shown that upon binding to 
its target protein or peptides, CaM “wrap around” its target peptide and form a 
compact globular conformation by bending its central helix. The central helix of CaM 














Figure 6.8: (A) Ca2+-CaM structure (PDB code 3CLN) and (B) apo CaM structure 
(PDB code 1CFC). Figure generated using PyMol (DeLano & Lam, 2005). 
 
 
6.4.1 CaM-binding proteins 
CaM-binding proteins can be divided into two classes-1) calcium-dependent and 2) 
calcium-independent modes of binding.  Ca2+-CaM can bind to target proteins to alter 
their function, acting as part of a calcium signal transduction pathway. Ca2+-CaM 
binding proteins include kinases, phosphatases, second messenger signalling proteins, 
cytoskeletal and muscle proteins.   CaM binding proteins can have one or more CaM-
binding domains. Key interaction occurs through bulky hydrophobic residues such as 
Phe, Trp, Ile, Leu, or Val. C-terminal domain of CaM is more negatively charged 
than the N-terminal domain. Peptides with +ve charged (H, K, and R) interacts with –
ve charged residue on CaM. C-terminal domain of CaM was able to accommodate 
larger volume than the N-terminal domain (Osawa et al., 1999). Figure 6.9 shows 









Figure 6.9: Example of CaM binding proteins. This figure is adapted from (O'Day, 
2003) 
 
CaM binding motifs have been divided into following category based on the distance 
of key bulky hydrophobic residue- 
1-14 motif: 
In this class, key bulky residues are separated by12 residues. Examples are -smooth 
muscle and skeletal muscle myosin light chain kinase (smMLCK, skMLCK). 
1-10 motif:  
The key bulky residues are separated by 8 residues. For example- Ca2+/CaM 
dependent kinase II (CaMKII). 
1-16 motif:  
 92
Here the key bulky residues are separated by 14 residues. For Example- Ca2+/CaM 
dependent protein kinase kinase (CaMKK). 
IQ motif: 
IQ motif is the group of sequences on the target peptide through which it interacts 
with CaM mostly in Ca2+ dependent manner. A general sequence of IQ motif is given 
below  
IQ                 (I/L/V)QXXXRXXXX(R/K) 
IQ motifs have been first identified in Nm (Alexander et al., 1988a) but was first 
characterized in myosins (Zuhlke et al., 1999, Cheney & Mooseker, 1992) and 
calcium channels, such as the L-type calcium channel. 
6.4.2 apo CaM-binding proteins 
 apo CaM utilizes unique binding motifs, which show greater homology than Ca2+-
CaM binding motifs.   apo CaM binding proteins are neuroproteins, receptors, second 
messenger signalling proteins, cytoskeletal and muscle proteins. apo CaM and target 
protein interaction are shown to affect neurotransmitter production, nerve growth, 
synaptic development, intracellular movement and smooth muscle relaxation.    
 
In summary, Neuromodulin (Nm) and Neurogranin (Ng) are the two neuron specific 
proteins expressed at pre and post synaptic terminal, respectively for the synaptic 
dialogue of efficacy changes underlying in learning and memory.   Both proteins bind 
to CaM through IQ motif (I/L/V)QXXXRXXXX(R/K)  under a low Ca2+ micro-
environment and dissociates when Ca2+ level increases (Andreasen et al., 1983). In 
resting neurons, much of the CaM is associated with these two proteins and also with 
 93
regulator of CaM signalling (RCS).  Ca2+-dependent phosphorylation of Nm (Ser41) 
and Ng (Ser36) by PKC also prevents its binding to apo CaM (Caroni, 2001) (Huang 
et al, 1993). Ser36-phosphorylated Ng is unable to bind either CaM or phospahtidic 
acid (Diez-Guerra, 2010).  Thus Nm and Ng play the similar role at the pre and post 
synaptic termini respectively by controlling the concentration of apo CaM in neurons. 
Nm and Ng share high sequence similarity within a 20-amino-acid region that 
contains an IQ motif.  Both are acid stable, hydrophilic proteins and belongs to the 
calpactin protein family (Ran et al., 2003). 
 
Our study shows that Nm and Ng are intrinsically unstructured proteins in vitro under 
physiological conditions. The unstructured nature of the two proteins probably better 
suited for its interaction with multiple proteins and to perform the various function as 
mentioned above. In order to gain the further insight into the molecular mechanism of 
learning and memory formation, in this chapter we report the structural and functional 
studies of these two proteins involved in important cognitive functions. This is the 
first time the structure of Nm/Ng and CaM complexes have been reported.  
 
6.5 Objective of this study 
The goal of the proposed study is to gain insight into the molecular mechanism of 
learning and memory formation through the structural and functional studies of these 
two (Nm and Ng) proteins involved in important cognitive functions through its 
interactions with CaM in neuron cell. Even though these proteins have been known 
for many years, so far there is no representative structure available for this family of 
neuron specific substrate proteins.  Structure-function relationships that will be 
established from the studies of these neuron specific substrate proteins will help to 
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understand their implications in the functional regulation of the nervous system. The 
objective of this study is to understand the structure and function of these two 
proteins through the following experimental approaches:-  
 
1. Cloning of various genes constructs to over express the recombinant proteins.  
2. Biophysical characterization of Nm and Ng by using different techniques to 
understand the in vitro behaviour of these proteins. 
3. Thermodynamic characterization of interaction with full length Nm and Ng and their 
IQ peptides with apo and Ca2+/CaM using isothermal calorimetry.  
4. Determination of the complex crystal structures’ of IQ motif peptides derived from 
Nm and Ng with apo CaM and Ca2+/CaM.  
5. Structure function analysis to understand the role of these proteins in the molecular 
mechanism of learning and memory formation.   
 
6.6 Methods 
6.6.1 Expression, purification and characterization of Nm and Ng 
Full-length Nm (accession no NP_032109) and Ng (accession no NP_071312) 
proteins were expressed from E. coli BL21 (DE3) cells harboring respective genes in 
pQE30 (Qiagen, USA) plasmids. E. coli cells were cultured in 1L LB media 
(supplemented with 100 µg/mL ampicillin) at 37°C until the OD600 reached between 
0.6-0.8 AU. The culture was then maintained at 16°C before protein expression was 
induced with 0.15 mM IPTG. Cells were grown for 16 h at 16°C, and harvested by 
centrifugation at 9800 g for 10 min. Cell pellets from 2 L cell culture were 
resuspended in 100 ml lysis buffer (50 mM Tris-HCl (pH-8.0), 500 mM NaCl, 10% 
v/v glycerol, 20 mM Imidazole, 20 mM BME and 0.1 mM PMSF). After sonication, 
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the cell lysate was centrifuged at 39,000 g for 30 min. The supernatant was mixed 
with 5 ml of Ni–NTA (Qiagen, USA), and washed thrice using 30 ml lysis buffer. 
The protein was released from the Ni-NTA resin using 10 ml lysis buffer 
supplemented with 300 mM imidazole. The protein was then passed through a 
HiLoad™ 16/60 Superdex™ 200 prep grade gel filtration column and eluted in a 
buffer (50 mM NaH2PO4.2H2O (pH 7.4), 300 mM NaCl, 20 mM BME, and 0.1% 
Triton X100). The mean stokes radius and apparent molecular weight of Nm and Ng 
were calculated using standard curves (Figure 10B and 10C) generated based on the 
elution volumes  of  proteins  of  known molecular weight and stokes radius(le Maire 
et al., 1987). Dynamic Light Scattering (Protein solutions, USA) and Circular 
Dichroism (JASCO J-175, Japan) experiments were performed in the same buffer. 1H 
NMR experiments were performed in 50 mM sodium phosphate (pH 7.4), 100 mM 
NaCl and 95% H2O plus 5% D2O at 250 C with 16 K data point. Suppression of the 
water resonance was achieved through the WATERGATE technique.  
 
Based on the complex structures, an arginine to alanine point mutation of full-length 
Nm/Ng (Arg43Ala/Arg38Ala) was generated using inverse PCR and purified as 
described above.  
 
6.6.2 Cloning, expression and purification of CaM constructs 
NmIQ2 (34-57) and NgIQ2 (27-50) motifs were linked to the C-terminus of 
CaM via a 5-glycine flexible linker (CaM-(Gly)5-NmIQ2 and CaM-(Gly)5-NgIQ2) 
using a three-step phusion PCR procedure, as described by Ye et al (Ye et al., 2006). 
The final PCR product was digested with Nde1 and Xho1 restriction enzymes (New 
England Biolabs, UK) along with the pGS21a vector (GeneScript, USA). Predigested 
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CaM-(Gly)5-NmIQ2 and CaM-(Gly)5-NgIQ2 genes and pGS21a vector were ligated, 
transformed into chemically competent E. coli DH5α cells and screened for positive 
colony formation. The CaM-(Gly)5-NmIQ2 and CaM-(Gly)5-NgIQ2 gene sequences 
were verified by DNA sequencing.  
For protein expression, the recombinant plasmids (pGS21a- CaM-(Gly)5-
NmIQ2 and pGS21a- CaM-(Gly)5-NgIQ2) were transformed into E. coli BL21 (DE3) 
chemically competent cell and plated onto agar plates. A single colony was used to 
inoculate 100 ml of the LB media containing 100 µg/ml ampicillin. The expression 
and purification strategy was similar to that of full-length Nm/Ng described above, 
with the exception that the proteins were passed through HiLoad™ 16/60 Superdex™ 
75 prep grade columns (Amersham Biosciences, Sweden) and eluted with a buffer 
consisting of 20 mM Imidazole pH 8.0, 100 mM NaCl, 2 mM EGTA (buffer A).  
A similar expression and purification procedure was adopted for (His)6-tagged 
CaM  (accession no NP_033920) from pETDuet-1 vector (Novagen, USA). CaM 
protein was eluted from gel filtration column in either buffer A or a buffer containing 
20 mM HEPES (pH 8.0), 100 mM NaCl and 10 mM CaCl2 (buffer B) to elute apo 
CaM or Ca2+/CaM, respectively. For SeMet SAD phasing, selenomethionine-labeled 
proteins were produced using LeMaster media(Hendrickson et al., 1990) following a 
similar procedure as described above.  All protein purification steps were carried out 
at 4°C unless otherwise indicated.  
  
6.6.3 Isothermal titration calorimetry  
Isothermal titration calorimetry was used to study the binding of full-length 
wild type Nm/Ng proteins, full-length mutant Nm/Ng proteins and their synthetic 
wild-type IQ motif peptides (Nm (NmIQ1: aa32-50 and NmIQ2: aa34-57) and Ng 
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(NgIQ1: aa27-45 and NgIQ2: aa27-50)) (Figure 13-15 and Figure 18) with Ca2+/CaM 
(in a buffer B) and apo CaM (in a buffer A). ITC experiments were performed using 
either VP-ITC or iTC200 calorimeter (indicated in brackets) (Microcal, LLC) at room 
temperature (24°C) with 0.2 (or 0.04) ml of Ca2+/CaM or apo CaM in the injector 
cell, and 1.8 (or 0.2) ml of Nm/NmIQ or Ng/NgIQ in the sample cell, respectively.  
Samples were thoroughly degassed and centrifuged to remove precipitates. All 
experiments used 10 (or 2) µl volumes per injection. Two consecutive injections were 
separated by 5 (or 2) min to allow the peak to return to baseline. Data from control 
experiments, i.e., titration of protein/peptides into buffer, were subtracted from each 
experiment to compensate for the heat of dilution.  ITC data were analyzed with a 
single-site fitting model using the following equation  
( ) ( )( )PKHPKEVQ totototi 111 1/ +Δ=  
Where totiQ  is the total heat after the ith injection, V0 is the volume of calorimetric 
cell, K1 is the observed equilibrium constants for each site, P is the concentration of 
free ligand, and ΔH1 is enthalpy changes. The corresponding of Kobs and ΔH were 
obtained by fitting the experimental data to model using Origin 7.0 software 
(OriginLab Corp. MA, USA).  
 
6.6.4 Crystallization and structure determination  
 Crystallization trails for apo CaM-(Gly)5-NmIQ2, apo CaM-(Gly)5-NgIQ2 
and complexes of Ca2+/CaM with NmIQ2 and NgIQ2 synthetic peptides (1:3 molar 
ratios) were performed with a protein concentration of 10-12 mg/ml using the 
hanging drop vapor diffusion method at room temperature. The initially identified 
conditions from Hampton Research (Aliso Viejo, CA, USA) and Qiagen (Valencia, 
CA, USA) were further optimized. Best crystals of Ca2+/CaM-NmIQ2 and Ca2+/CaM-
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NgIQ2 complexes were obtained using a reservoir solution consisting of 100 mM 
Tris-HCl (pH 8.0), 8-10% v/v PEG 6 K, 5-10 mM ZnCl2 and 10% v/v glycerol. apo 
CaM-(Gly)5-NmIQ2 complex crystals were obtained from a condition consisting of 
0.12 mM MgAcO, 8% PEG 3350 and 10% EtOH. Similarly, the apo CaM-(Gly)5-
NgIQ2 complex crystals were obtained using a condition consisting of  0.1 M 
imidazole (pH 8.0) and 1.2 M sodium citrate tribasic dihydrate. Where necessary, 
crystals were cryo-protected with reservoir condition supplemented with 10% 
glycerol and flash-cooled in N2 cold stream at 100 K.  
The molecular replacement method did not yield any structure solution, which 
led us to collect the Single wavelength Anomalous Dispersion (SAD) data sets in the 
synchrotron beam line X8C (NSLS, Brookhaven National Laboratory) and 13B1 
SW6 (National Synchrotron Radiation Research Center (NSRRC), Taiwan) using a 
Quantum 4-CCD detector (Area Detector Systems Corp Poway, CA, USA).  All data 
sets were processed using HKL2000(Otwinowski & Minor, 1997). Heavy atom (Se) 
location, phasing and density modification were performed using the program 
ShelxC/D/E (Sheldrick, 2008), and model building was carried out with the program  
Buccaneer (Cowtan, 2006) in CCP4 . Where necessary, the model was manually built 
in COOT(Emsley & Cowtan, 2004) and refinement was carried out in 
Refmac5(Vagin et al., 2004).  At the final stage of refinement, well-ordered water 
molecules were included. The models have good stereochemistry, as analyzed by 
PROCHECK(Laskowski et al., 1993) (Table 2). All structure-related figures reported 





6.6.5 Protein Data Bank accession code 
Coordinates and structure factors of all the apo CaM-(Gly)5-NmIQ2  and apo 
CaM-(Gly)5-NgIQ2 has been deposited with RCSB Protein Data Bank with codes 
4E53 and 4E50.  
 
6.7 Results  
6.7.1 Nm and Ng are intrinsically unstructured proteins  
6.7.1.1 Sequence analysis predicts Nm and Ng are intrinsically unstructured 
proteins 
Compared with the average folded protein (Romero et al., 2001), the signature 
for proteins with a probable lack of folding is a low sequence complexity and an 
amino acid composition with a low proportion of order-promoting amino acids (W, 
Y, F, C, I, L and N) and a high proportion of disorder-promoting amino acids (P, E, 
K, S and Q). Consequently, intrinsically unstructured proteins have high net charge at 
neutral pH and a low overall hydrophobicity. The amino acid compositions of Nm 
and Ng are unique. Nm consists of 4.4% order-promoting amino acids, and 45.8% 
disorder-promoting amino acids. Similarly, Ng consists of 15.4% order-promoting 
and 27% disorder-promoting amino acids. Thus, the amino acid composition of both 
proteins suggests that their structures are intrinsically unstructured (Table 6.1). 
Further the acidic pI and low hydrophobicity of these two proteins indicates that they 
are unfolded or unstable. Moreover Nm/Ng migrates slowly in SDS-PAGE, 







Table 6.1: The amino acid composition of the Nm and Ng. The order promoting 
amino acids (*) (W, Y, F, C, I, L and N) and disorder promoting amino acids ($) (P, 
E, K, S and Q) are indicated.  
 
 Nm Ng 








Ala (A) 46 20.3 11   14.1 
Arg (R) 5   2.2 4      5.1 
Asn (N)* 2   0.9 1      1.3 
Asp (D) 22   9.7 8   10.3 
Cys (C)* 2    0.9 4      5.1 
Gln (Q)$ 9   4.0 1      1.3 
Glu (E)$ 34  15.0 2      2.6 
Gly (G) 13   5.7 18   23.1 
His (H) 3   1.3 1      1.3 
Ile (I)* 3   1.3 4      5.1 
Leu (L)* 2   0.9 2      2.6 
Lys (K)$ 30 13.2 6      7.7 
Met (M) 2   0.9 2      2.6 
Phe (F)* 1   0.4 1      1.3 
Pro (P)$ 17   7.5 7      9.0 
Ser (S)$ 14   6.2 5      6.4 
Thr (T) 15   6.6 1      1.3 
Trp (W)* 0   0.0 0   0.0 
Tyr (Y)* 0   0.0 0   0.0 
Val (V) 7   3.1 0   0.0 
 
6.7.1.2 Gel Filtration shows Nm and Ng exist in unfolded globular state 
 The elution profiles of Nm and Ng from Superdex 200 gel filtration columns 
revealed an elution time shorter than that which would be expected for a monomer of 
a similar sized globular protein. The symmetry of the elution peaks indicates that Nm 
and Ng both eluted as a homogeneous species (Figure 6.10). The calculated mean 
stokes radius (RS) of 39 Ǻ for Nm and 10 Ǻ for Ng corresponds to a molecular weight 
of ~100 kDa and ~22 kDa, respectively. Thus, the estimated molecular weight from 
gel filtration chromatography is around 3-4 times higher than that for the expected 
monomeric MW of 23.6 kDa (Nm) and 7.6 kDa (Ng). The elution volume for the 
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denatured (6 M Guanidinium HCl-treated) Nm and Ng corresponds to an RS of 46 Ǻ 
and 14 Ǻ, respectively. No significant differences were observed in the gel filtration 
profile upon treating these proteins with the denaturing agent. Further, the Dynamic 
Light Scattering (DLS) experiments for these two proteins showed higher molecular 
weights and were highly monodispersed in solution. Together, these results suggest 
that Nm and Ng exist in a largely unfolded premolten globular state.  
 
 
















































Figure 6.10:  (A) Hydrodynamic analyses of Nm (solid line, 73 ml) and Ng (dotted 
line, 103 ml) monitored at 280 nm in Superdex 200 Gel filtration column. The 









−=  , where, Ve 
= elution volume, V0 = void volume (45 ml as calculated using Blue dextran 2000) 
and Vc = total column volume (120 ml). Analytical gel filtration chromatography 
standard curves for (B) Kav versus Stokes radius (Rs); and (C) Kav versus molecular 
weight (MW) of standard monomeric MW markers (High Molecular Weight Gel 
Filtration Calibration Kit, Amersham Biosciences, Sweden). The Stokes radius and 
hydrodynamic molecular weight was calculated using the equations shown.  Open 
ellipsoid and asterisk corresponds to Nm and Ng, respectively. Because of the very 
high Kav value (0.773), Ng is not shown in graph C. 
 
 
6.7.1.3 Residual Secondary structure from Far UV-CD 
CD spectra of Nm and Ng showed an intense minimum at 201 and 204 nm 
respectively, indicating the presence of disordered regions in these proteins. The 
CD analysis further supports that Nm and Ng both have residual secondary 
structural elements (mainly α helix) and  suggests that these two proteins exist in 
premolten globular conformational state of protein quartet model (Uversky, 2002) 











Figure 6.11: (A) Far-UV CD spectra of the purified native Nm (dotted line) and Ng 
(solid line). Data from three independent scans were averaged and the background 
spectrum of the buffer was subtracted.  1H NMR spectrum of (B) Nm and (C) Ng. 
Far-UV CD and 1H NMR spectrum suggest unfolded nature of these proteins in 
solution.  
 
6.7.1.4 NMR spectroscopy suggests Nm and Ng are natively unfolded proteins 
1H NMR is sensitive method capable of distinguishing between folded and 
unfolded proteins through a small dispersion of the amide backbone chemical 
shift(Rehm et al., 2002). Particularly, the appearance of a large and broad signal at 
approximately 8.3 ppm is an indicator for a disordered protein. On the other hand, 
signal dispersion beyond 8.5 ppm (8.5-11 ppm) indicates a folded protein. Further, in 
the aliphatic region of the 1H NMR spectrum between +1.0 and -1.0 ppm, a large-
signal dispersion versus a steep flank of the dominant peak at approximately 1.0 ppm 
will separate a structured protein from an unfolded protein. The NMR spectra of Nm 
and Ng were very similar to those previously observed for other unstructured proteins 
(Figure 6.11B and C). The resonance of both protein’s methyl group protons (at 0.9 
C 
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and 0.95 ppm) and amide groups (around 8.4 ppm); along with very limited spectral 
dispersion of these signals, indicate the lack of a stable tertiary structure in both Nm 
and Ng (Figure 6.11B and C).  
Thus, the biophysical studies on Nm and Ng support the classification of these 
proteins as intrinsically unstructured, lacking a compact globular fold, and having 
very little or no secondary structure (Permyakov et al., 2003, Kleerekoper & Putkey, 
2009, De Guzman et al., 2004).  
 
6.7.2 Isothermal calorimetry 
The sequence alignment of known CaM binding peptides showed that each 
has one or two key aromatic residues, a few basic amino acids (located at N or C 
terminal) and other hydrophobic amino acids (Figure 6.12). Nm and Ng protein 
sequences do not have any aromatic residues at the N-terminal region of the IQ motif. 
However, both IQ motifs are enriched with basic amino acids in the C-terminal 
region. Based on the sequence alignment, we selected two different lengths of 
peptides surrounding the IQ motif for Nm (NmIQ1 and NmIQ2) and Ng (NgIQ1 and 
NgIQ2) in order to determine which length better mimics the interactions of their full-
length counterparts with CaM.  The ITC experiments were performed with full length 
and IQ peptides of Nm/Ng with CaM (Table 6.2 and Figure 6.13-6.15).   Table 6.2 
report the preliminary results of the ITC experiments. Currently we are in the process 
of analyzing all ITC data that we have obtained. Based on the analysis, if needed 
additional ITC experiments will be performed.  
ITC experiments revealed that the full-length Nm and Ng bind to apo CaM (in 
the absence of Ca2+) with a higher affinity than CaM in the presence of Ca2+. These 
observations are consistent with the previous fluorescence experiments (Andreasen et 
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al., 1983) (Table 6.2). Further, the ITC results show that NmIQ2 and NgIQ2 peptides 
have a similar affinity toward apo CaM as their full-length counterparts; thus, the IQ2 
peptides almost mimic their full-length proteins. Nm and Ng interact with CaM 




Figure 6.12: Structure-based sequence alignment of CaM binding peptides from 
different proteins. Sequence analysis shows a critical aromatic amino acid  that 
anchors the peptide into CaM; a positively charged amino acid (blue) that determines 
the orientation of the peptide between two lobes of CaM; and hydrophobic amino 
acids (red) that are involved in binding. The pdb codes are given in parenthesis.  
 
Table 6.2: Thermodynamic parameters for Nm and Ng with CaM interactions 
 
 
 Nm-apo CaM Nm-Ca2+/CaM 
 
 Nm NmIQ1 NmIQ2 Nm(R43A) Nm NmIQ1 NmIQ2 Nm(R43A) 
 
KAX 106 (M−1) 
 
3.2 (± 0.4) 0.02(± 0.09) 0.56(± 0.042) 0.077(± 0.018) 1.95(± 0.68) 0.0096(± 0.0024) 0.039(± 0.0039) 0.077(± 0.009) 
N 
 
0.97 (±0.02) 1.12(±0.19) 0.95(±0.00) 1.04(±0.2) 0.99.(±0.04) 0.84(±0.10) 0.93(±0.02) 1.06(±0.17) 
ΔH 
(kcal/mol) 
-163.9(±4.9) -0.87(±0.15) -230.2(±8.5) 2.49(±0.7) -61 (±3.9) -2.08(±0.35) -14.6(±0.38) -1.514 (±0.3) 
ΔS 
(cal/mol/deg) 
-520 15.36 -745.8 30.6 -176 -11.4 -27 17.28 
 
 Ng-apo CaM Ng-Ca2+/CaM 
 
 Ng NgIQ1 NgIQ2 Ng(R38A) Ng NgIQ1 NgIQ2 Ng(R38A) 
 
KAX 106 (M−1)* 
 
13.0(± 2.1) 0.043(± 0.0040) 0.17(± 0.04) 0.2(± 0.04) 1.01(± 0.24) 0.0093(± 0.003) 0.061(± 0.007) 0.063(± 0.03) 
N 
 
0.96(±0.01) 1.11(±0.013) 0.94 (±0.03) 1.00(±0.07) 0.96(±0.03) 1.24(±0.16) 1.07(±0.018) 1.05(±0.07) 
ΔH 
(kcal/mol) 
-28.3(±0.5) -6.5(±0.10) -5.8 (±0.34) 1.07(±0.12) -70.1(±3.9)  0.96(±0.24) -15.4(±0.3) -8.814(±0.80) 
ΔS 
(cal/mol/deg)
-62.5 -0.17 4.77 27.86 -207.4 16.8 -28.8 -7.57 
 
  
Ka- Association constant 
N- Number of binding sites 
ΔH- Change in enthalpy 
ΔS- Change in entropy 
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Figure 6.13: ITC profiles of (A) Nm (B) NmIQ2 (C) Ng and (D) NgIQ2 peptides 
titrated against apo CaM.  Upper panels show the raw data; lower panels show the 









Figure 6.14: ITC profiles of Nm/Ng and NmIQ2/NgIQ2 peptides titrated against 
Ca2+/CaM. (A) Nm titrated against Ca2+/CaM; (B) NmIQ2 peptide titrated against 
Ca2+/CaM; (C) Ng titrated against Ca2+/CaM; and (D) NgIQ2 peptide titrated against 
Ca2+/CaM. Upper panels show the raw data; lower panels show the heat release for 
each injection. The data is fitted using a single-site binding model.  
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Figure 6.15: ITC profiles of NmIQ1 and NgIQ1 peptides titrated against CaM. (A) 
NmIQ1 titrated against Ca2+/CaM; (B) NmIQ1 titration against apo CaM; (C) NgIQ1 
titrated against Ca2+/CaM; (D) NgIQ1 titrated against apo CaM. Upper panels show 
the raw data; lower panels show the heat release for each injection. The data is fitted 
using a single-site binding model.  
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6.7.3 Nm/Ng CaM complex structural studies 
The present studies combined with literature clearly showed that Nm and Ng 
are intrinsically unstructured proteins. Brief attempts to crystallize the full-length Nm 
and Ng alone and in complex with apo and Ca2+/CaM did not yield crystals. This led 
us to crystallize the IQ motif peptides in complex with CaM instead. The best 
peptides to better mimic the full-length proteins were selected. Initially, we co-
crystallized the synthetic IQ motif peptides with apo CaM and Ca2+/CaM. Crystals 
were obtained only for Ca2+/CaM-NmIQ2 and Ca2+/CaM-NgIQ2 complexes, with 
similar crystallization conditions. Although the presence of these peptides in their 
complex crystals was verified, there was no electron density observed for the 
peptides.  
 
6.7.3.1 Ca2+/CaM-NmIQ2 and Ca2+/CaM-NgIQ2 structures 
In both structures, the His-tag and the N-terminal 5 residues were disordered 
and not included in the model. The two molecules of the asymmetric unit were tightly 
packed. Ca2+ ions were well-defined in the electron density map, located at each EF-
hand (helix-loop-helix) motif, while no electron density was observed for the IQ 
peptides. The structure of Ca2+/CaM in the presence of Nm/Ng-IQ peptides was 
similar, with an rmsd of 0.7 Å for 139 Cα atoms. The following section discusses the 
high resolution structure of Ca2+/CaM crystallized in the presence of NmIQ peptide 
(Table 6.3). 
A search for structural homologs in the pdb database using DALI program 
(Holm & Sander, 1995) did not  provide any similar structures. In the present 
structure, the Ca2+/CaM adopt a unique conformation, with the relative disposition of 
its two lobes being completely different from any of the previously reported CaM 
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structures. However, a one-to-one comparison of individual domains showed no 














The close examination of current Ca2+/CaM structure with previously reported apo 
and Ca2+-bound CaM complexes (including IQ motif complexes) showed that 
residues Ala74-Asp79 of the central helix (aa 65-92) were unwound, and bent by 
~90° near Arg75, which reoriented the C-lobe in a perpendicular direction to the 
central helix (Figure 6.16). While a transformation of α-helix-to-loops has been 
previously reported (Shen et al., 2004, Aoyagi et al., 2003), the kink observed at 
Arg75 is unique, the current structure of CaM likely to be one among its many 
possible conformations.  
 
It must be noted that the Ca2+/CaM-NmIQ2 crystals were grown in conditions 
containing 5-10 mM ZnCl2 and 10 mM CaCl2. Zn2+ has been reported to bind CaM 
with higher affinity than Ca2+. Based on the B-factor and structural comparison, we 
assigned the electron density in our structures as Ca2+ ions. Nonetheless, the 
previously reported Zn2+-bound, N-lobe CaM structure resembles apo CaM 
structures, with no conformational changes observed in the central helix, despite the 
Zn2+ binding to both EF-hand motifs in N-lobe(Warren et al., 2007). Thus, the 
present conformational change observed in the central helix of the CaM is 







Table 6.3: Crystallographic data and refinement statistics  
 
aRsym = ∑|Ii – <I>|/|Ii| where Ii is the intensity of the ith measurement, and <I> is the mean intensity 
for that reflection. 
bReflections with I>σ was used in the refinement. 
cRwork = |Fobs – Fcalc|/|Fobs| where Fcalc and Fobs are the calculated and observed structure factor 
amplitudes, respectively. 
dRfree = as for Rwork, but for 5-7% of the total reflections chosen at random and omitted from 
refinement. 
eIndividual B-factor refinements were calculated. 
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0.978 1.541 0.964 0.979 
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Completeness (%) 99.3 (98.9) 93.4 (71.6) 95.2(85.5) 
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Fig. 6.16: (A) Cα superimposition of Ca2+/CaM (blue) with apo CaM-(Gly)5-
NmIQ2 (magenta) and other structures of CaM from the pdb database 2BE6 
(yellow), 2F2P (white), 2F3Y (light blue), 2O60 (pale green), 2VAY (teal), 
2W73 (red), 2X0G (orange), 3BXQ (deep purple), 3DVE (gray), 1CDM (olive) 
and 3CLN (dark salmon). The results show that Ca2+/CaM-NmIQ2 adopts a 
unique conformation.  (B) 2Fo-Fc electron density map for the fragment aa65-




6.7.3.2 apo CaM-(Gly)5-NmIQ2 and apo CaM-(Gly)5-NgIQ2 structures 
 NmIQ2 and NgIQ2 both 24aa  peptides were linked to the C-terminal of CaM 
through 5 aa Gly linker (referred to as apo CaM-(Gly)5-NmIQ2 and apo CaM-(Gly)5-
NgIQ2), crystallized, and their structure independently solved by Single wavelength 
Anomalous Dispersion (SAD) method. Both models were refined up to 2.6 Å 
resolutions, with good stereo chemical parameters (Table 6.3). The apo CaM-(Gly)5-
NmIQ2 has 3 molecules in the asymmetric unit, whereas apo CaM-(Gly)5-NgIQ2 has 
1 molecule in the asymmetric unit. CaM in both structures existed in an extended 
conformation, with peptide binding to the C-lobe. The structures of both complexes 
were different (rmsd 4.1Å for 122 Cα atoms). However, the peptide bound to the C-
lobes of both CaM structures superimposed with an rmsd of 2.1 Å (Figure 6.19). The 
bound peptides are well defined in the electron density map (Figure 6.17) and the 
models have good geometry. No density was observed for any metal ion in any of the 
divalent metal ion binding sites.  
The amino acid distribution of CaM makes the C-lobe more negatively 
charged than the N-lobe(Osawa et al., 1999). Notably, NmIQ2/NgIQ2 peptides 
lacked key, bulky hydrophobic residues, but were rich in positively charged amino 
acids (Figure 6.12). The crystal structure revealed that the bound NmIQ2/NgIQ2 
peptide adopted an α-helical structure that was almost perpendicular to the central α-
helix of CaM, making several contacts with the C-lobe and a few contacts with 
central helix of CaM (Figure 6.17 and 6.19 and Table 6.4).  
 
6.7.3.2.1 apo CaM-(Gly)5-NmIQ2 
Residues Lys55-Gly57 of the NmIQ2 peptide were not well-defined in the 
electron density map and were not included in the model. PKC phosphorylation site 
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Ser41 of NmIQ2 was observed to be in contact with Glu115 of CaM, residing in a 
negatively charged cavity consisting of Asp119, Glu120 and Glu121 (Figure 6.19). 
Previous studies have shown that a Ser41-to-Asn (S41N) mutation in full-length Nm 
allows Nm to retain its affinity for apo CaM-Sepharose, whereas a Ser41-to-Asp 
(S41D) mutation causes the affinity to be lost (Chapman et al., 1991). Another report 
shows that the phosphorylation of Ser41 by PKC blocks the Nm and CaM association 
and interrupts several learning- and memory-associated functions (Holahan & 
Routtenberg, 2008, Hulo et al., 2002). Therefore, we suggest that upon 
phosphorylation by PKC or substitution with a negatively charged amino acid at 
position 41 (e.g. Asp), may interrupt the interactions between Nm and CaM due to 
electrostatic repulsion and steric hindrances. By comparison, substitution with a 
neutral amino acid (e.g. Asn) will not affect the interaction (Figure 6.19). A separate 
study shows that genetically over expressed wild type Nm can enhance the learning 
and LTP in transgenic mice; but that over expressed mutant Nm (S41A), does 
not(Routtenberg et al., 2000). Others have shown that interactions between a S41A 
Nm mutant and CaM in PC12B cells become insensitive to Ca2+ concentrations in 
vitro, with the mutation inhibiting the association of Nm with the membrane skeleton 
of  PC12B cells(Meiri et al., 1996). These findings suggest that the Ser41 
phosphorylation site is the main target for enhancing cognitive ability. 
The fragment Arg43-Leu51 of Nm has been reported to bind CaM-Sepharose 
both in the presence  of Ca2+ or in an excess of EGTA, and can be eluted with 150 
mM KCl(Alexander et al., 1988b). By comparison, the Gln39-Lys55 fragment (Trp 
substituted for Phe42) binding to CaM-Sepharose becomes Ca2+-sensitive (Alexander 
et al., 1988b). Phe42 of Nm interacts with CaM hydrophobically, and an increase in 
hydrophobicity at this position (Phe-to-Trp substitution) increases the Nm-CaM 
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affinity by 10-fold (Chapman et al., 1991). The present crystal structure showed that 
the fragment Ile38-Phe42 of Nm is in the vicinity of the EF-motifs (i.e., a Ca2+-
binding site) of CaM (Figure 6.19). Thus, the binding of fragment Ile38-Phe42 
(hence, Gln39-Lys55) is affected by binding of Ca2+ to the EF-motif.  However, the 
Arg43-Leu51 fragment (mainly basic amino acids) binds through electrostatic 
interactions near the central helix of CaM, away from the EF-motifs, and thus 
remains insensitive to Ca2+.  Residues, such as Ile38, Gln39, Phe42 and Arg43, 
anchor the NmIQ2 peptide in a groove formed by the central helix and EF-motifs of 
CaM.  Further, Arg43 of the IQ peptide makes several contacts with the residues of 
the central helix of CaM, such as Glu85, Asp81 and Ser82. Our site-directed point 
mutation of Arg43Ala on the full-length Nm drastically reduced its affinity with CaM 











Figure 6.17: Cartoon representations of the structure of (A) apo CaM-(Gly)5-
NmIQ2 and (B) apo CaM-(Gly)5-NgIQ2 complexes, with CaM (orange), NmIQ2 
(cyan) and NgIQ2 (magenta). N and C-termini of the IQ peptides are labeled. 2Fo-
Fc electron density maps of (C) NmIQ2 and (D) NgIQ2 peptides. Maps are 




Figure 6.18: ITC profile of R43A Nm and R38A Ng titrated against CaM- (A) 
R43A Nm titrated against Ca2+/CaM; (B) R43A Nm titrated against apo CaM; (C) 
R38A Ng titrated against Ca2+/CaM; (D) R38A Ng titrated against apo CaM. Upper 
panels show the raw data; lower panels show the heat release for each injection. The 
data is fitted using a single-site binding model.  
 
 119
6.7.3.2.2 apo CaM-(Gly)5-NgIQ2 
Similar to the apo CaM-(Gly)5-NmIQ2 complex, the CaM in apo CaM-
(Gly)5-NgIQ2 complex existed in extended conformation (Figure 6.17B). No electron 
density was observed for the loop between Met52 and Gly62 of CaM or for the last 
two residues (Gly49 and Glu50) of NgIQ2; these residues were not included in the 
model. Interestingly, the CaM interacting peptide of Ng is from the nearest 
symmetry-related molecule and the bound peptide is in the opposite direction to that 
observed in the CaM-(Gly)5-NmIQ2 complex (Figure 6.20). The N-terminal part of 
the peptide is deeply buried in a cleft formed by the helices from the EF-motif of 
CaM. The conserved residues of the IQ motif [(I/L/V)QXXXRXXXX(R/K)] interact 
with CaM and anchor the Ng molecule (Figure 6.19B). Studies have previously 
shown that the Ser36-phosphorylated Ng is unable to bind CaM and phosphatidic acid 
(Dominguez-Gonzalez et al., 2007, Diez-Guerra, 2010). In the apo CaM-(Gly)5-
NgIQ2 structure, Ser36 is buried in a pocket surrounded by negatively charged 
residues, such as Glu83, Glu84, Glu85, Glu88 and Asp96 (Figure 6.19B). We suggest 
that upon phosphorylation by PKC, Ser36 may have electrostatic repulsion by these 
negative charged residues of CaM and also may have steric effects; hence, preventing 










Table 6.4: Interactions between NmIQ2 and NgIQ2 with CaM. 
 
NmIQ2 residue (atom) CaM residue (atom) Interatomic 
distances in Å 
H-bond   
Lys37 (NZ) Glu121 (OE) 2.98 
Ser41  (OG) Glu115 (OE2) 2.81 
Arg43 (NE) Glu85   (OE1) 2.42 
Arg43 (NH2) Ser82    (OG)  3.49 
Lys49 (O) Glu88   (OE2) 3.27 
Lys50 (NZ)  Asp81   (OD2) 2.92 
Hydrophobic interactions   
Ile38 (CD1) Met125 (SD) 3.54 
Phe42(CD2) Phe142 (CZ) 3.23 
Ile46 (CG1) Ala89   (CB) 2.96 
 
NgIQ2 residue (atom)   
 
H-bond   
Gln34 (OE1) Glu115  (N) 2.78 
Gln34 (NE2) Leu113  (O)  2.55 
Gln34 (NE2) Met110 (O) 2.64 
Arg38 (NH1)  Glu115 (OE1) 2.45 
Arg38 (NH2) Glu121 (OE2)   2.91 
Arg43 (NH2) Met146 (O)   3.32 
Hydrophobic interactions   
Ile33    (CD) Phe90   (CD2)  3.19 
Ile33    (CD) Ala89   (CB)   3.23 
Ile33    (CG2) Met125 (CE) 3.40 






Figure 6.19: Interactions of (A) NmIQ2 and (B) NgIQ2 peptides with the C-lobe of 
CaM. IQ peptides are shown in surface representation and key side chains involved in 
interactions are shown as sticks. The electrostatic surface potential of C-lobes of CaM 




It has been shown that Ser36-phosphorylated Ng does not bind to CaM and is unable 
to potentiate synaptic transmission and synaptic strength (Han et al., 2007, Zhong et 
al., 2009, Gerges et al., 2009, Zhong & Gerges, 2010). The identified key CaM 
interacting residues of NgIQ2 (Ile33, Ser36 and Arg38) are consistent with  the 
residues identified in the full-length Ng for in vivo CaM binding (Prichard et al., 
1999). The Ile33Gln (I33Q) point mutation completely inhibits the binding, while 
Ser36Asp (S36D) and Arg38Gln (R38Q) mutations only reduce Ng-CaM binding 
(Prichard et al., 1999). In the crystal structure, Ile33 makes strong interactions with 
the hydrophobic cluster consisting of Ala89, Phe90 and Met125 (Table 6.4). A point 
mutation at this position with a non-hydrophobic amino acid (e.g. I33Q) might disrupt 
the hydrophobic interaction, also create steric hindrances and abolishes the interaction 
between Ng and CaM (Prichard et al., 1999). Moreover, a point mutation of S36D in 
Ng would add a negative charge to this position, but cause less of an effect than if it 
were to be phosphorylated on Ser36 (Prichard et al., 1999); i.e., while a S36D 
mutation will reduce Ng-CaM binding, a phosphorylation event will completely 
abolish it. Similarly, Arg38 of Ng makes hydrogen bonding contacts with Glu115 and 
Glu121 of CaM (Table 6.4). Our site-directed point mutation of Arg38Ala on the full-
length Ng resulted in a reduced binding with CaM in the presence or absence of Ca2+ 
(Table 6.2 and Figure 6.18).  
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Figure 6.20.: In the crystal structure of apo CaM-(Gly)5-Ng, the CaM interacting 
peptide of Ng is from the nearest symmetry-related molecule. Each molecule of 








Figure 6.21: Superposition of the structures of NmIQ2 (cyan) and NgIQ2 (magenta) 
bound to C-lobe of apo CaM (orange). Side chains of Arg43 of Nm and Arg38 of Ng 




Nm and Ng have been the subjects of intense study for their potential roles in 
brain development and neural plasticity (Zhong et al., 2009, Gerges et al., 2009, 
Routtenberg et al., 2000). Both proteins are members of the calpacitin family and 
share a conserved IQ domain that mediates interactions between Ca2+, CaM, and PKC 
signalling pathways (Gerendasy, 1999, Chapman et al., 1991, Huang et al., 1993). 
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PKC phosphorylates Ser41 (Nm) and Ser36 (Ng) within the IQ motif and 
phosphorylated proteins are unable to bind CaM. One proposed biochemical function 
for Nm and Ng is that it sequesters CaM at the membrane in the vicinity of ‘CaM-
activated enzymes’ under low Ca2+ conditions at the pre- and post-synaptic terminals, 
respectively (Andreasen et al., 1983, Alexander et al., 1988b, Huang et al., 1993). 
Therefore, Nm and Ng might serve as a Ca2+-regulated modulators of CaM activity in 
neurons. Moreover, the strict conservation of the region containing the IQ motif in all 
vertebrates suggests that both the PKC phosphorylation site and the CaM binding 
feature are essential to the functions of Nm and Ng (Clayton et al., 2009). Although 
the functions of Nm and Ng have been well-established, the intrinsically unstructured 
nature of these two proteins, and the consequential lack of structural information, has 
seriously hampered a complete understanding of the interaction between Nm/Ng and 
CaM.  
From our study, we show that once the Nm/Ng binds with CaM, the 
interacting IQ motif regions of Nm/Ng adopt an α-helical conformation. Similar 
conformational changes of intrinsically unstructured binding partners of CaM have 
been shown for chicken gizzard caldesmon via physico-chemical experiments 
(Permyakov et al., 2003), and for PEP-19 (Kleerekoper & Putkey, 2009) and calponin 
(Pfuhl et al., 2011) via NMR. Further, a previous NMR study reported a helical 
structure for the activation domain of CITED2, which is unstructured in its free form, 
in complex with its partner TAZ1 (De Guzman et al., 2004). The present report on the 
Nm/Ng with CaM is the first crystal structure of any neuron specific intrinsically 
disordered proteins complexed with their binding partner. Besides the IQ motif, Nm 
and Ng share no sequence homology. However, the N-terminal domain of both 
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proteins is highly conserved among vertebrates, and the structural information 
provided here might be extended to other homologs.  
Our initial aim was to crystallize the synthetic IQ peptides in complex with 
Ca2+/CaM and apo CaM; however, crystals were only obtained for the Ca2+-bound 
form. Further, no electron density was observed for the peptides in Ca2+/CaM, and the 
CaM adopted a unique conformation so far not observed. CaM has been shown to 
adopt a wide variety of conformations to interact with different targets (Figure 6.16). 
The N- and C-terminal lobes move in to wrap around the hydrophobic residues of a 
target molecule (Meador et al., 1993, Gifford et al., 2011). Besides this classical 
mode of binding, CaM bound to Oedema factor adopts an extended 
conformation(Drum et al., 2002), where part of the central α-helix transforms into 
loops for peptide interactions(Shen et al., 2004, Aoyagi et al., 2003), and binds to the 
target peptide only via the C-terminal lobe(Elshorst et al., 1999, Pagnozzi et al., 
2010). In addition, NMR and other spectroscopic studies have shown that the central 
α-helix is flexible in solution, and that the backbone atoms between residues Lys77 
and Asp80 undergo conformational changes(van der Spoel et al., 1996).   
Our previous study has shown that the complex between Ng and CaM is not 
stable for the structure determination by NMR (Ran et al., 2003). In order to study the 
interactions of Nm/Ng with CaM, the full-length mimic IQ peptide fusion proteins 
were generated, wherein the IQ peptides were fused at the gene level to the C-
terminus of CaM via a flexible linker. The linking of peptides to CaM has been 
previously reported(Ye et al., 2006) and, based on the analysis on CaM structure, we 
generated various length linker constructs and finally optimized with a linker of 
(Gly)5 to provide an appropriate degree of flexibility for the peptide to bind at its 
naturally preferred site on CaM. For the linked peptide complexes, crystals were 
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obtained only for apo CaM (Ca2+ free). It is worth mentioning here that previously 
the crystal structure of a chimeric protein containing CaM linked via (Gly)5 to the 
CaM-binding domain (CBD) peptide of calcineurin was  determined (Ye et al., 2006). 
Subsequently CaM structure was solved in complexed with synthetic peptide without 
any linker [(Gly)5]. The structure was essentially similar to the others, with the same 
interacting residues and binding regions (Ye et al., 2006, Ye et al., 2008). Although 
the CBD peptide and the present study IQ peptides of Nm/Ng were linked to CaM 
with (Gly)5, the interactions of these peptides with CaM were all different. 
Interestingly, the bound peptides in the NmIQ2-CaM and NgIQ2-CaM complexes 
were orientated in the opposite direction (Figure 6.21).   Besides, in the NmIQ2-CaM 
complex, Arg43 of Nm makes several contacts with the central helix; whereas, in the 
NgIQ2-CaM complex, Arg38 of Ng mainly interact the C-lobe of CaM. Yet, the 
interacting residues of Nm/Ng identified through the IQ motif crystal complexes are 
consistent with our site-directed mutagenesis on the full-length proteins, as well as 
those identified through in vivo mutagenesis approaches (Prichard et al., 1999, 
Chapman et al., 1991, Ran et al., 2003).  Together all these observations confirm that 
linker does not restrict the range of possible orientations for intermolecular 
interactions. The observed interactions of Nm/Nm peptides with CaM represent their 
natural interactions. The linked complex approach provides a useful mechanism to 
study protein-protein interactions of weakly interacting proteins, as well as for the 
interactions of intrinsically unstructured proteins.   
Located in the IQ motif, the PKC phosphorylation site is the functionally 
important site of Nm and Ng. In the complex crystal structure, the PKC 
phosphorylation sites, Ser41 and Ser36 of Nm and Ng, respectively, are completely 
surrounded by negatively charged amino acids. Consequently, the phosphorylation of 
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this Ser residue will repel Nm/Ng from CaM due to electrostatic repulsion and steric 
hindrance. This clearly explains why the phosphorylation of Ser by PKC blocks the 
Nm/Ng association with CaM and interrupts several learning- and memory-associated 
functions (Routtenberg et al., 2000, Hulo et al., 2002, Holahan & Routtenberg, 2008, 
Zhong & Gerges, 2010, Chapman et al., 1991, Meiri et al., 1996, Han et al., 2007).  
In summary, this is the first report of the crystal structures of the intrinsically 
unstructured, neuron-specific substrate proteins Nm/Ng as IQ peptides in complex 
with CaM. The unstructured IQ peptides (24 aa) interact with the C-lobe of CaM and 
gain an α-helical conformation. Biophysical studies with full-length Nm/Ng 
confirmed their unstructured properties in solution. Further, ITC studies revealed that 
full-length Nm/Ng, their mutants, and their IQ peptides bind strongly to apo CaM 
than to Ca2+/CaM. This study provides the structural basis for the association of 
Nm/Ng with CaM, a crucial interaction for several learning- and memory-associated 






































We have met our objectives of studying the two neuron specific proteins Nm and Ng 
and their peptide complexes with apo CaM and Ca2+/CaM.  Biophysical studies 
indicate that these two proteins, Nm and Ng are “intrinsically unstructured proteins” 
belonging to a class that exhibit little secondary structure, high flexibility, and low 
compactness.  Gel filtration chromatography of the purified proteins clearly indicates 
their respective Stoke radius is larger than what would be expected from crystal 
structure of the other globular proteins of similar molecular weight. Far-UV circular 
dichroism (CD), nuclear magnetic resonance (NMR), sequence analysis and aberrant 
mobility in SDS-PAGE indicate the intrinsically unstructured nature of these two 
proteins.  
Crystallographic study showed that the Ca2+/CaM adopts an unique  conformation in 
the presence of IQ peptides and explains the reason why these two proteins show 
unusual CaM binding features; low affinity for Ca2+/CaM and higher affinity for apo 
CaM.  Crystal structure of apo CaM and IQ peptides showed that CaM adopts an 
extended conformation. In both structures, apo CaM-(Gly)5-NmIQ2 and apo CaM-
(Gly)5-NgIQ2, the IQ peptides interact with mainly C-domain of the CaM.  The 
interacting residues are consistent with the earlier predictions arrived through 
mutagenesis and NMR studies. Linking of the peptides to CaM has been reported 
previously for at least   two cases and each of them has different interactions with 
CaM (which depends on the interacting partner) was shown(Ye et al., 2006), and is 
independent of whether the peptide is linked or not. Length of the linker (5XGly) is 
large enough to give flexibility to peptide for docking into its specific binding site on 
CaM.  This method might be applicable for other low affinity protein-protein or 
protein-peptides interactions. However, the length of the linkers needs to be 
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optimized. Besides we have carried out interaction studies using ITC. The ITC results 
and structural studies showed that only a small motif of full length Nm and Ng is 
sufficient to make interactions with CaM. Consistent with the previous studies, ITC 
results showed that both proteins (and IQ peptides) interact with higher affinity to apo 
CaM than with Ca2+/CaM. In this study we show for the first time the crystal structure 
of the neuron specific intrinsically unstructured proteins and this study explains how 
the unstructured proteins gain structure upon binding with its partners. 
 
7.2 Future studies 
 
With the knowledge gained through this study, our future objective is to crystallize 
the full length Nm/Ng complexed with CaM. Following this, structure based 
functional studies will be conducted to understand the role of these substrate proteins. 
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